<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6701809</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0221446</article-id><article-id pub-id-type="publisher-id">PONE-D-19-12706</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Leptospira</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Leptospira</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Leptospira</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drug Research and Development</subject><subj-group><subject>Drug Discovery</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Leptospira</subject><subj-group><subject>Leptospira Interrogans</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Leptospira</subject><subj-group><subject>Leptospira Interrogans</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Leptospira</subject><subj-group><subject>Leptospira Interrogans</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Enzymology</subject><subj-group><subject>Enzyme Inhibitors</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Pharmacokinetics</subject><subj-group><subject>Drug Metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Biosynthesis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Metabolic Pathways</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>An <italic>in silico</italic> approach towards identification of novel drug targets in pathogenic species of <italic>Leptospira</italic></article-title><alt-title alt-title-type="running-head">Identification of novel drug targets against pathogenic strains of <italic>Leptospira</italic></alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Reena</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Verma</surname><given-names>Rashi</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pradhan</surname><given-names>Dibyabhaba</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Jain</surname><given-names>Arun Kumar</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Software</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Umamaheswari</surname><given-names>Amineni</given-names></name><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2657-7153</contrib-id><name><surname>Rai</surname><given-names>Chandra Shekhar</given-names></name><role content-type="http://credit.casrai.org/">Project administration</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>University School of Information, Communication &#x00026; Technology, Guru Gobind Singh Indraprastha University, New Delhi, India</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Biomedical Informatics Centre, National Institute of Pathology-Indian Council of Medical Research, New Delhi, India</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Computational Genomics Centre, Indian Council of Medical Research, Campus&#x02014;All India Institute of Medical Sciences, New Delhi, India</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Bioinformatics, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Dikhit</surname><given-names>Manas Ranjan</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Rajendra Memorial Research Institute of Medical Sciences, INDIA</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>csrai@ipu.ac.in</email> (CSR); <email>dbpinfo@gmail.com</email> (DP)</corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>8</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>14</volume><issue>8</issue><elocation-id>e0221446</elocation-id><history><date date-type="received"><day>5</day><month>5</month><year>2019</year></date><date date-type="accepted"><day>6</day><month>8</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 Gupta et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Gupta et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0221446.pdf"/><abstract><p>Leptospirosis is one of the leading zoonotic infections worldwide. As with other infectious diseases, report of antimicrobial resistance to existing therapeutic arsenal poses challenges in the management of disease. Hence, identification of novel drug targets for the pathogen deems essential. Present study used combined approach of comparative and subtractive genomics to identify putative drug targets. Crucial genes of 16 pathogenic <italic>Leptospira</italic> strains were filtered and subjected to homology search <italic>via</italic> target identification tool &#x0201c;TiD&#x0201d;. Thereafter, comparative analysis was performed for non-homologous, essential genes to accomplish the broad-spectrum drug target. Consequently, 37 essential genes were found to be conserved in at least 10 strains of <italic>Leptospira</italic>. Further, prioritization of resultant set of genes revealed 18 were hubs in protein&#x02013;protein interaction network. Sixteen putative targets among the hub genes were conserved in all strains of <italic>Leptospira</italic>. Out of sixteen, fourteen were enzymes while 8 were novel and 4 were involved in virulence mechanism. In addition, genome scale metabolic network reconstruction and choke point analysis revealed cobA (porphyrin and chlorophyll metabolism) and thiL (thiamine metabolism) as chokepoints in their respective metabolic pathways. The proposed hub genes could act as putative broad-spectrum drug targets for <italic>Leptospira</italic> species, however, these putative targets should be validated to ensure them as real one prior to utilizing them for target based lead discovery.</p></abstract><funding-group><funding-statement>The author(s) received no specific funding for this work.</funding-statement></funding-group><counts><fig-count count="8"/><table-count count="5"/><page-count count="22"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the manuscript and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the manuscript and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>The globally widespread occurrence of bacterial resistance to present drugs has stressed the necessity to find novel targets [<xref rid="pone.0221446.ref001" ref-type="bibr">1</xref>]. Human leptospirosis is a zoonotic infection caused by pathogenic spirochete <italic>Leptospira</italic> with the prevalence of about one million cases per year of which 60,000 failed to survive annually [<xref rid="pone.0221446.ref002" ref-type="bibr">2</xref>&#x02013;<xref rid="pone.0221446.ref004" ref-type="bibr">4</xref>]. It is an endemic, occupational as well as recreational disease in tropical and rural areas [<xref rid="pone.0221446.ref005" ref-type="bibr">5</xref>&#x02013;<xref rid="pone.0221446.ref007" ref-type="bibr">7</xref>]. Humans, who are exposed frequently to the diseased rodents, pet animals and polluted water, are at high risk of leptospirosis [<xref rid="pone.0221446.ref008" ref-type="bibr">8</xref>]. Clinical symptoms of the disease range from mild fever, vomiting, flu like illness, headache, diarrhea and muscle ache to multi-organ system complications which include kidney, liver, central nervous system and lungs with death rates 5% to 40% [<xref rid="pone.0221446.ref009" ref-type="bibr">9</xref>&#x02013;<xref rid="pone.0221446.ref010" ref-type="bibr">10</xref>].</p><p><italic>Leptospira</italic> infection cases have been highly recorded from Indonesia, Thailand, India, Sri Lanka and Maldives. India has been recognized as a major hub for <italic>Leptospira</italic> spp. to cause leptospirosis since 20<sup>th</sup> century as it is a confluence of environmental, socio-economic and demographic factors [<xref rid="pone.0221446.ref011" ref-type="bibr">11</xref>]. Climate changes, population size, global warming, natural calamities (cyclone, floods), lack of facilities, poor sanitary infrastructure and clinical suspicion <italic>etc</italic>. increase the incidence of leptospirosis in coastal and rainy states of India like Gujarat, Kerala, Tamil Nadu, Maharashtra and Andaman-Nicobar islands [<xref rid="pone.0221446.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0221446.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pone.0221446.ref013" ref-type="bibr">13</xref>].Various studies conducted in past few years confirmed higher prevalence of leptospirosis. Most substantial outbreaks have been observed in Chennai floods in 2015, spontaneous eruptions in Gujarat in 2011, flash floods in Mumbai in 2005 and cyclone in Orissa in 1999.</p><p>Taylor &#x00026; Goyal <italic>et al</italic>., 1931, isolated <italic>L</italic>. <italic>andamans</italic> and <italic>L</italic>. <italic>grippotyphosa</italic> from diseased patients [<xref rid="pone.0221446.ref014" ref-type="bibr">14</xref>]. In 1960, Dalal P. M. provided the evidence of <italic>L</italic>. <italic>icterohaemorrhagiae</italic> antigen in jaundice patients. Similar report was submitted by Joseph K. M. in 1983 who found <italic>Leptospira</italic> infection in patients of jaundice. Muthusethupathi and Shivkumar observed renal failure in patients of Madras due to Leptospirosis. In 1996, Saravanan &#x00026; Rajendran isolated <italic>L</italic>. <italic>javanica</italic> from urine sample of renal failure, cases of Chennai. Gujarat reported 130 deaths in 2011 within a span of two months due to leptospirosis. Recently, Kochi and Kerala reported 209 cases with 12 deaths. In October 2012, Gujarat reported 16 deaths. These reports highlights the continuous alarming jeopardy the disease presents at this hour.</p><p>Presently, treatment of severe leptospirosis is still unclear [<xref rid="pone.0221446.ref015" ref-type="bibr">15</xref>]. Antibiotics (penicillin, cephalosporins, azithromycin, doxycycline) and vaccines were relatively unsuccessful against <italic>Leptospira</italic> spp. This emphasizes the need of a new drug targets for evolution of competent drug that kill the pathogen [<xref rid="pone.0221446.ref016" ref-type="bibr">16</xref>&#x02013;<xref rid="pone.0221446.ref018" ref-type="bibr">18</xref>]. In the last two decades, classical research approach was being used to classify protein targets towards the expansion of subunit and recombinant vaccines against leptospirosis. In 2005, whole genome analysis was carried out to classify potential vaccine against <italic>L</italic>. <italic>Interrogans</italic> [<xref rid="pone.0221446.ref019" ref-type="bibr">19</xref>]. Amineni <italic>et al</italic>., 2010 proposed 88 putative drug targets for two serovars of <italic>L</italic>. <italic>interrogans</italic> [<xref rid="pone.0221446.ref020" ref-type="bibr">20</xref>]. Lack of data, information as well as methodology, restrict the development of novel potent targets. Previous studies lack the gaps or information that would be useful in revealing of potent target like (1) coverage of all pathogenic strains, (2) metabolic reconstruction and system biology analysis, (3) exploration of hub genes that are analogous for endurance and virulence of pathogen, (4) recognition of choke point enzymes or reactions and (5) common target among the pathogenic strains.</p><p>In this study, we have tried to design a protocol to overcome the limitations of previous studies. Our protocol includes complete genome analysis, subtractive approach, comparative approach, and protein-protein interaction analysis that ultimately link to metabolomics. Various bioinformatics tools and cheminformatics techniques represent an attractive source of alternative method for target identification. The drug targets could be used, sequentially, for optimization and new lead recognition through free energy calculation, molecular modeling, molecular dynamics simulations, multiple docking strategies and drug-likeliness determination to establish new antibacterial agent against leptospirosis.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><p>Pathogenic strains of <italic>Leptospira</italic> were subjected to a broad-spectrum anti-leptospiral target identification strategy that involves subtractive and comparative genomics approach along with protein-protein interaction network analysis. The complete protocol of the target identification is shown in <xref ref-type="fig" rid="pone.0221446.g001">Fig 1</xref>.</p><fig id="pone.0221446.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0221446.g001</object-id><label>Fig 1</label><caption><title>The complete protocol of the target identification and prioritization of pathogenic strains of <italic>Leptospira</italic>.</title></caption><graphic xlink:href="pone.0221446.g001"/></fig><sec id="sec003"><title>Classification of <italic>Leptospira</italic> strains</title><p>Up to 2016, global character was lacking in classification of <italic>Leptospira</italic>. Fouts <italic>et al</italic> (2016) and Caimi <italic>et al</italic> (2017) have established the classification of <italic>Leptospira</italic> by wide range inter-species genomic comparison of all known infectious and non-infectious species of the bacterium [<xref rid="pone.0221446.ref021" ref-type="bibr">21</xref>&#x02013;<xref rid="pone.0221446.ref022" ref-type="bibr">22</xref>]. In the present study, we have followed the systems established by Fouts and Caimi to classify various species of <italic>Leptospira</italic> as pathogenic, intermediate and saprophytic to humans. List of classified <italic>Leptospira</italic> strains was prepared and target mining using subtractive genomics, comparative genomics along with protein-protein interaction network analysis was restricted to pathogenic strains only.</p></sec><sec id="sec004"><title>Mining of potential drug targets</title><p>Whole genome of pathogenic strains was retrieved and processed using target identification software called TiD developed by our team [<xref rid="pone.0221446.ref023" ref-type="bibr">23</xref>]. TiD is a standalone program. It consists of modules for paralog analysis, non-homolog analysis and essentiality analysis that exclude duplicates proteins, homolog of human and its gut flora proteins from the essential protein dataset [<xref rid="pone.0221446.ref024" ref-type="bibr">24</xref>&#x02013;<xref rid="pone.0221446.ref026" ref-type="bibr">26</xref>]. Target prioritization module annotates the screened essential protein dataset on druggability and virulence which is essential for pathogen survival as well as pathogenicity [<xref rid="pone.0221446.ref027" ref-type="bibr">27</xref>].</p><p>Target identification and prioritization parameters were adapted from our previously published paper [<xref rid="pone.0221446.ref023" ref-type="bibr">23</xref>]. The standard protocol for target identification was used to remove paralogs from pathogenic leptospiral proteome and, then, define the list of essential genes that are homologs to entries present in Database of Essential Genes (DEG) with e-value &#x02264; 10<sup>&#x02212;10</sup>, bit score &#x02265; 100. Further, the proteins homology was checked with human and gut microbes. The resulting dataset was compiled as putative drug targets and annotated for virulence, drug likeliness and mapped with UniProt identifiers (<ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org/">http://www.uniprot.org/</ext-link>).</p></sec><sec id="sec005"><title>Metabolic pathway analysis</title><p>The mapped dataset of putative targets was prioritized at the KAAS (KEGG Automatic Annotation Server) to know the involvement of these proteins in metabolic pathways. Functional annotation of these targets was also acquired through BLAST comparisons against KEGG database [<xref rid="pone.0221446.ref028" ref-type="bibr">28</xref>]. KAAS server has programmed procedure that depends on sequence similarities and bi-directional best hit data to assign K numbers that permits recreation of KEGG pathways.</p></sec><sec id="sec006"><title>Subcellular localization</title><p>Subcellular localization along with the biological significance of inimitable drug targets was analyzed in CELLO v.2.5. It is a multi-class support vector machine sorting method. This identifies targets as membrane proteins, cellular proteins or surface protein [<xref rid="pone.0221446.ref029" ref-type="bibr">29</xref>]. Results obtained were further analyzed in subcellular localization prediction tool pSORTb v.3.0. It is first standalone software that predicts the location of proteins for all prokaryotes including archaea and bacteria with atypical membrane/cell wall topologies with high accuracy [<xref rid="pone.0221446.ref030" ref-type="bibr">30</xref>].</p></sec><sec id="sec007"><title>Genome scale metabolic network reconstruction</title><p>The metabolic network reconstruction of <italic>L</italic>. <italic>borgpetersenii</italic> serovar Hardjo-bovis str. L550 and <italic>L</italic>. <italic>interrogans</italic> serovar Copenhageni str. Fiocruz L1-130 were performed using &#x02018;PathoLogic&#x02019; plugins of pathway tools [<xref rid="pone.0221446.ref031" ref-type="bibr">31</xref>]. GenBank file format of each chromosome of organism were used as input in &#x02018;Build&#x02019; section that involved &#x02018;Replicon Editor&#x02019;, &#x02018;Trial Parse&#x02019;, &#x02018;Automated Build&#x02019; and Refine. Pathway hole filler was used to fill the gaps of reconstructed network and then, save the database for choke point analysis.</p></sec><sec id="sec008"><title>Choke-point analysis</title><p>"Chokepoint responses" are the reactions which exclusively catalyze a particular substrate or preferentially deliver a particular product [<xref rid="pone.0221446.ref032" ref-type="bibr">32</xref>&#x02013;<xref rid="pone.0221446.ref033" ref-type="bibr">33</xref>]. To distinguish potential drug targets, we searched choke points reactions using Pathway tool. Choke point analysis includes all reactions that raise several pathways while excludes those reactions catalyzed by more than one enzyme and found in human. Result of choke point analysis was compared with putative targets. Results of Pathway tools were also validated with BioCyc webserver [<xref rid="pone.0221446.ref034" ref-type="bibr">34</xref>]. It is an online server that comprised of 13075 pathway genome databases and provides unified data on the genomes and metabolic pathways of thousands of sequenced organisms which are built <italic>via</italic> metabolic network reconstruction software(s).</p></sec><sec id="sec009"><title>Sequence-structure relationship</title><p>A multiple sequence alignment was created for cobA and thiL sequences of <italic>Leptospira</italic> strains using clustalX and UniProt. Structurally conserved elements were identified and formatted with ESPript 3.0 to obtain the conserved and semi conserved residues of both the chokepoints [<xref rid="pone.0221446.ref035" ref-type="bibr">35</xref>]. The secondary structure of cobA and thiL were determined by using PsiPred server. Further, a three dimensional structure model of a target sequences were built by Modeller 9.17 [<xref rid="pone.0221446.ref036" ref-type="bibr">36</xref>]. Energy minimization of best modelled structure having least DOPE score was performed using YASARA server [<xref rid="pone.0221446.ref037" ref-type="bibr">37</xref>]. Validation of energy minimized structures was performed through SAVES server ((<ext-link ext-link-type="uri" xlink:href="http://services.mbi.ucla.edu/SAVES/">http://services.mbi.ucla.edu/SAVES/</ext-link>), QMEAN and ProSA [<xref rid="pone.0221446.ref038" ref-type="bibr">38</xref>&#x02013;<xref rid="pone.0221446.ref039" ref-type="bibr">39</xref>]. The catalytic pocket and active site residues of validated model were defined using CASTp and PyMOL-2.3.2 [<xref rid="pone.0221446.ref040" ref-type="bibr">40</xref>&#x02013;<xref rid="pone.0221446.ref041" ref-type="bibr">41</xref>].</p></sec><sec id="sec010"><title>Protein-protein network analysis</title><p>Protein-protein interaction data is available for two strains of <italic>Leptospira</italic> in string database. Therefore, network analysis was restricted to these two strains. PPI network of putative drug targets of both strains were constructed in STRING app of Cytoscape v3.7.1 with confidence score &#x02265;0.4 [<xref rid="pone.0221446.ref042" ref-type="bibr">42</xref>]. Network interaction data was figured through network analyzer module [<xref rid="pone.0221446.ref043" ref-type="bibr">43</xref>]. Putative drug targets with interacting partners&#x02019; &#x02265;30 in <italic>Leptospira</italic> proteome were subjected to MCODE plugin for the functional module detection [<xref rid="pone.0221446.ref044" ref-type="bibr">44</xref>]. The cutoff parameters used for molecular complex detection were degree cutoff = 2, node score cutoff = 0.2, k-core = 2, and maximum depth = 100. The highest ranked module was chosen for gene ontology and functionality. Gene enrichment analysis of interacting nodes was also carried in STRING app. The results of two strains were checked for conservancy among the pathogenic strains using multiple sequence alignment tool ClustalX2 [<xref rid="pone.0221446.ref045" ref-type="bibr">45</xref>].</p></sec></sec><sec sec-type="conclusions" id="sec011"><title>Results and discussion</title><p>The current study is an adoption of advanced subtractive and comparative genomic approach and further augmented to protein-protein interaction network and metabolomics analysis. The unique and essential proteins are significant for <italic>Leptospira</italic> growth, survival and pathogenicity. A search for the hub proteins and choke enzymes in the unique and essential pathways is therefore considered as a promising approach to deal with the challenging leptospirosis infection.</p><sec id="sec012"><title>Classification of <italic>Leptospira</italic> strain</title><p><italic>In silico</italic> and <italic>in vitro</italic> target identification research to cure leptospirosis, till date, have been more focused towards most pathogenic <italic>L</italic>. <italic>interrogans</italic> serovars named Lai and Copenhagani [<xref rid="pone.0221446.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0221446.ref046" ref-type="bibr">46</xref>&#x02013;<xref rid="pone.0221446.ref047" ref-type="bibr">47</xref>]. The present study tried to cover all pathogenic strains of <italic>Leptospira</italic> which are responsible for causing infectious disease. We grouped <italic>Leptospira</italic> strains based on their pathogenicity. Out of 27 retrieved strains from NCBI FTP server, 16 are observed to be pathogenic in nature, 5 are intermediate and 6 are saprophytic in nature (<xref rid="pone.0221446.t001" ref-type="table">Table 1</xref>). Sixteen pathogenic strains of <italic>Leptospira</italic> were selected for putative drug target mining [<xref rid="pone.0221446.ref021" ref-type="bibr">21</xref>&#x02013;<xref rid="pone.0221446.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0221446.ref048" ref-type="bibr">48</xref>].</p><table-wrap id="pone.0221446.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0221446.t001</object-id><label>Table 1</label><caption><title>List of <italic>Leptospira</italic> strains and their pathogenicity.</title></caption><alternatives><graphic id="pone.0221446.t001g" xlink:href="pone.0221446.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">S. No.</th><th align="center" rowspan="1" colspan="1"><italic>Leptospira</italic> strain</th><th align="center" rowspan="1" colspan="1">Accession ID</th><th align="center" rowspan="1" colspan="1">Pathogenicity</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1"><bold>1</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira alexanderi</italic> serovar Manhao 3 str. L 60</td><td align="left" rowspan="1" colspan="1">GCA_000243815.3_gls454062v02</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>2</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira</italic> alstonii</td><td align="left" rowspan="1" colspan="1">GCA_001729245.1_ASM172924v1</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>3</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira borgpetersenii</italic> serovar Hardjo-bovis str. L550</td><td align="left" rowspan="1" colspan="1">GCA_000013945.1_ASM1394v1</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>4</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira interrogans</italic> serovar Copenhageni str. Fiocruz L1-130</td><td align="left" rowspan="1" colspan="1">GCA_000007685.1_ASM768v1</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>5</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira kirschneri</italic> serovar Cynopteri str. 3522 CT</td><td align="left" rowspan="1" colspan="1">GCA_000243695.3_gls454049v02</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>6</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira kmetyi</italic> serovar Malaysia str. Bejo-Iso9</td><td align="left" rowspan="1" colspan="1">GCA_000243735.3_gls454052v1.0</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>7</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira mayottensis</italic> 200901122</td><td align="left" rowspan="1" colspan="1">GCA_000306335.2_gls454125v02</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>8</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira noguchii</italic> serovar Panama str. CZ214</td><td align="left" rowspan="1" colspan="1">GCA_000306255.2_gls454059v02</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>9</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira santarosai</italic> serovar Shermani str. LT 821</td><td align="left" rowspan="1" colspan="1">GCA_000313175.2_ASM31317v2</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>10</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira</italic> sp. B5-022</td><td align="left" rowspan="1" colspan="1">GCA_000347035.1_gls454192v01</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>11</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira</italic> sp. Fiocruz LV3954</td><td align="left" rowspan="1" colspan="1">GCA_000306435.2_gls454068v2.0</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>12</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira</italic> sp. Fiocruz LV4135</td><td align="left" rowspan="1" colspan="1">GCA_000346675.1_gls454076v02</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>13</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira</italic> sp. P2653</td><td align="left" rowspan="1" colspan="1">GCA_000346955.1_gls454051v01</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>14</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira</italic> sp. ZV016</td><td align="left" rowspan="1" colspan="1">GCA_001584255.1_ASM158425v1</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>15</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira</italic> sp. serovar Kenya str. Sh9</td><td align="left" rowspan="1" colspan="1">GCA_000347195.1_gls454066v01</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>16</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira weilii</italic> serovar Topaz str. LT2116</td><td align="left" rowspan="1" colspan="1">GCA_000244815.3_gls454188v02</td><td align="center" rowspan="1" colspan="1">Pathogen</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>17</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira</italic> sp. CLM-U50</td><td align="left" rowspan="1" colspan="1">GCA_002150035.1_ASM215003v1</td><td align="center" rowspan="1" colspan="1">Pathogenic</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>18</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira meyeri</italic></td><td align="left" rowspan="1" colspan="1">GCA_000304275.1_gls454017v1.0</td><td align="center" rowspan="1" colspan="1">Saprophytic</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>19</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira terpstrae</italic></td><td align="left" rowspan="1" colspan="1">GCA_000332495.2_gls454203v02</td><td align="center" rowspan="1" colspan="1">Saprophytic</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>20</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira vanthielii</italic></td><td align="left" rowspan="1" colspan="1">GCA_000332455.2_gls454199v02</td><td align="center" rowspan="1" colspan="1">Saprophytic</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>21</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira wolbachii</italic></td><td align="left" rowspan="1" colspan="1">GCA_000332515.2_gls454195v02</td><td align="center" rowspan="1" colspan="1">Saprophytic</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>22</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira yanagawae</italic></td><td align="left" rowspan="1" colspan="1">GCA_000332475.2_gls454202v02</td><td align="center" rowspan="1" colspan="1">Saprophytic</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>23</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira biflexa</italic></td><td align="left" rowspan="1" colspan="1">GCA_000017685.1_ASM1768v1</td><td align="center" rowspan="1" colspan="1">Saprophytic</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>24</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira fainiei</italic></td><td align="left" rowspan="1" colspan="1">GCA_000306235.2_gls454058v2.0</td><td align="center" rowspan="1" colspan="1">Intermediate</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>25</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira inadai</italic></td><td align="left" rowspan="1" colspan="1">GCA_000243675.3_gls454047v02</td><td align="center" rowspan="1" colspan="1">Intermediate</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>26</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira licerasiae</italic></td><td align="left" rowspan="1" colspan="1">GCA_000244755.3_ASM24475v3</td><td align="center" rowspan="1" colspan="1">Intermediate</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>27</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira wolfii</italic></td><td align="left" rowspan="1" colspan="1">GCA_000306115.2_gls454061v02</td><td align="center" rowspan="1" colspan="1">Intermediate</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>28</bold></td><td align="left" rowspan="1" colspan="1"><italic>Leptospira bromii</italic></td><td align="left" rowspan="1" colspan="1">GCA_000243715.3_gls454050v02</td><td align="center" rowspan="1" colspan="1">Intermediate</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec013"><title>Sequence retrieval and putative drug targets mining</title><p>Complete amino acid sequence (*.faa) of sixteen serovars were successfully retrieved from NCBI-FTP server and subjected to TiD software. Nascimento <italic>et al</italic>., 2004 and Ren <italic>et al</italic>., 2003 reported the genomic size of <italic>L</italic>. <italic>interrogans i</italic>.<italic>e</italic>. to be 4.33-Mb chromosome I and 350-kb chromosome [<xref rid="pone.0221446.ref049" ref-type="bibr">49</xref>&#x02013;<xref rid="pone.0221446.ref050" ref-type="bibr">50</xref>]. In the present study, <italic>L</italic>. <italic>weilii</italic> serovar Topaz str. LT2116 proteome consists of most elevated number of proteins while <italic>L</italic>. <italic>borgpetersenii</italic> serovar Hardjo-bovis str. L550 has smallest proteome of 2945 proteins. About 13 pathogenic <italic>Leptospira</italic> strains have larger proteome than <italic>L</italic>. <italic>interrogans</italic>. Size of each proteome is mentioned in <xref ref-type="fig" rid="pone.0221446.g002">Fig 2A and 2B</xref>. Amineni <italic>et al</italic>., 2010 mentioned 158 essential genes of <italic>Lai</italic> and 218 genes of <italic>Copenhagni</italic> as human non homolog [<xref rid="pone.0221446.ref020" ref-type="bibr">20</xref>]. In our study, 736 proteins of <italic>L</italic>. <italic>kmetyi</italic> serovar Malaysia str. Bejo-Iso9 followed by 732 proteins of <italic>L</italic>. <italic>alstonii</italic> are identified as essential proteins. <italic>L</italic>. <italic>borgpetersenii</italic> serovar Hardjo-bovis str. L550 has lowest number of essential proteins (<xref ref-type="fig" rid="pone.0221446.g002">Fig 2A and 2B</xref>). <italic>L</italic>. <italic>kmetyi</italic> serovar Malaysia str. Bejo-Iso9 has uppermost whereas <italic>L</italic>. <italic>santarosai</italic> serovar Shermani str. LT 821 has minimum number of human non-homolog as well as gut flora non homolog protein. All strains of <italic>Leptospira</italic> have more than 36 novel drug targets and 31 virulent proteins. Results of drug target mining of each pathogenic strain are reported in <xref ref-type="fig" rid="pone.0221446.g002">Fig 2A and 2B</xref>.</p><fig id="pone.0221446.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0221446.g002</object-id><label>Fig 2</label><caption><title>Sequence retrieval and putative drug targets mining.</title><p>The plot of detailed protein products of <italic>L</italic>. <italic>alexandari</italic>, <italic>L</italic>. <italic>alstonii</italic>, <italic>L</italic>. <italic>borgpetersenii</italic>, <italic>L</italic>. <italic>interrogans</italic>, <italic>L</italic>. <italic>kirschneri</italic>, <italic>L</italic>. <italic>kmetyi</italic>, <italic>L</italic>. <italic>mayottensis</italic>, <italic>L</italic>. <italic>noguchii</italic> is represented in Fig 2A. The plot of detailed protein products of <italic>L</italic>. <italic>sp</italic>. B5-022, <italic>L</italic>. <italic>sp</italic>. Fiocruz LV3954, <italic>L</italic>. <italic>sp</italic>. Fiocruz LV4135, <italic>L</italic>. <italic>sp</italic>. P2653, <italic>L</italic>. <italic>sp</italic>. ZV016, <italic>L</italic>. <italic>sp</italic>. serovar Kenya str. Sh9, <italic>L</italic>. <italic>santarosai</italic> serovar Shermani str. LT 821, <italic>L</italic>. <italic>weilii</italic> serovar Topaz str. LT2116 is represented in Fig 2B. The resulted drug targets in each step represented using bar graph.</p></caption><graphic xlink:href="pone.0221446.g002"/></fig></sec><sec id="sec014"><title>Metabolic pathway analysis</title><p>Metabolic pathway analysis of the host-pathogen highlighted sixteen pathogen specific pathways such as biosynthesis of antibiotics, biosynthesis of secondary metabolites, degradation of aromatic compounds, microbial metabolism in diverse environments, sulfur metabolism, cysteine and methionine metabolism, seleno compound metabolism, lysine degradation, beta-alanine metabolism, glutathione metabolism, folate biosynthesis, lipopolysaccharide biosynthesis, ubiquinone and other terpenoid-quinone biosynthesis, phenylpropanoid biosynthesis, bacterial chemotaxis and flagellar assembly. These pathways were observed to have 34 communal drug targets (<xref ref-type="fig" rid="pone.0221446.g003">Fig 3</xref>, <xref rid="pone.0221446.t002" ref-type="table">Table 2</xref>). In addition, common drug targets were also identified from 8 pathways which are unique to the survival of 15 strains of <italic>Leptospira</italic>. The findings of our study are in same line with the Amineni <italic>et al</italic>., 2010 and Anisetty <italic>et al</italic>. 2005 [<xref rid="pone.0221446.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0221446.ref051" ref-type="bibr">51</xref>]. Among these common drug targets three are non enzyme and 31 are enzymes (<xref rid="pone.0221446.t002" ref-type="table">Table 2</xref>).</p><fig id="pone.0221446.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0221446.g003</object-id><label>Fig 3</label><caption><title>Metabolic pathways of the host and pathogen.</title><p>Sixteen pathways are unique to all strains of <italic>Leptospira</italic> to which 34 common genes were retrieved as putative drug targets. Red color denotes presence while Green color denotes absence of pathways from which common genes were retrieved for further analysis.</p></caption><graphic xlink:href="pone.0221446.g003"/></fig><table-wrap id="pone.0221446.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0221446.t002</object-id><label>Table 2</label><caption><title>List of common drug target extracted from the shared pathways of 16 <italic>Leptospira</italic> strains.</title></caption><alternatives><graphic id="pone.0221446.t002g" xlink:href="pone.0221446.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">S. No</th><th align="center" rowspan="1" colspan="1">Gene Product</th><th align="center" rowspan="1" colspan="1">Description</th><th align="center" rowspan="1" colspan="1">Enzyme/Non-Enzyme</th><th align="center" rowspan="1" colspan="1">Subcellular Localization</th><th align="center" rowspan="1" colspan="1">Choke Point</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1"><bold>1</bold></td><td align="center" rowspan="1" colspan="1">pdxA</td><td align="left" rowspan="1" colspan="1">Pyridoxal phosphate biosynthesis</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>2</bold></td><td align="center" rowspan="1" colspan="1">cysH</td><td align="left" rowspan="1" colspan="1">Phosphodenosine phosphosulphate reductase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>3</bold></td><td align="center" rowspan="1" colspan="1">Sir2</td><td align="left" rowspan="1" colspan="1">NAD-dependent protein deacylase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>4</bold></td><td align="center" rowspan="1" colspan="1">panB</td><td align="left" rowspan="1" colspan="1">3-methyl-2-oxobutanoate hydoxymethyltranferase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>5</bold></td><td align="center" rowspan="1" colspan="1">metX</td><td align="left" rowspan="1" colspan="1">Homoserine O-acetyltransferase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>6</bold></td><td align="center" rowspan="1" colspan="1">lpxA</td><td align="left" rowspan="1" colspan="1">acyl-[acyl-carrier-protein]&#x02014;UDP-N-acetylglucosamine O-acyltransferase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>7</bold></td><td align="center" rowspan="1" colspan="1">lpxB</td><td align="left" rowspan="1" colspan="1">Lipid-A-disaccharide synthase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Outer membrane</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>8</bold></td><td align="center" rowspan="1" colspan="1">ribE</td><td align="left" rowspan="1" colspan="1">6,7-dimethyl-8-ribityllumazine synthase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>9</bold></td><td align="center" rowspan="1" colspan="1">lpxK</td><td align="left" rowspan="1" colspan="1">Tetraacyldisaccharide 4&#x02019;-kinase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Outer membrane</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>10</bold></td><td align="center" rowspan="1" colspan="1">thiL</td><td align="left" rowspan="1" colspan="1">thiamine-phosphate kinase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">Choke Point</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>11</bold></td><td align="center" rowspan="1" colspan="1">cysD</td><td align="left" rowspan="1" colspan="1">Sulfate adenylyltransferase subunit 2</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>12</bold></td><td align="center" rowspan="1" colspan="1">kdsB</td><td align="left" rowspan="1" colspan="1">3-deoxy-manno-octulosonate cytidylyltransferase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>13</bold></td><td align="center" rowspan="1" colspan="1">panD</td><td align="left" rowspan="1" colspan="1">aspartate alpha-decarboxylase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>14</bold></td><td align="center" rowspan="1" colspan="1">wecB</td><td align="left" rowspan="1" colspan="1">UDP-N-acetylglucosamine2-epimerase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>15</bold></td><td align="center" rowspan="1" colspan="1">manA</td><td align="left" rowspan="1" colspan="1">Mannose-6-phosphate isomerase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>16</bold></td><td align="center" rowspan="1" colspan="1">trpF</td><td align="left" rowspan="1" colspan="1">N-(5'-phosphoribosyl)anthranilate isomerase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>17</bold></td><td align="center" rowspan="1" colspan="1">panC</td><td align="left" rowspan="1" colspan="1">Pantoate-beta-alanine ligase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>18</bold></td><td align="center" rowspan="1" colspan="1">gshA</td><td align="left" rowspan="1" colspan="1">Glutamate-cysteine ligase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>19</bold></td><td align="center" rowspan="1" colspan="1">kdtA</td><td align="left" rowspan="1" colspan="1">3-deoxy-D-manno-octulosonic-acid transferase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Transmembrane</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>20</bold></td><td align="center" rowspan="1" colspan="1">lpxC</td><td align="left" rowspan="1" colspan="1">UDP-3-O-[3-hydroxymyristoyl]N-acetylglucosamine deacetylase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>21</bold></td><td align="center" rowspan="1" colspan="1">lpxD</td><td align="left" rowspan="1" colspan="1">UDP-3-O-(3-hydroxymyristoyl)glucosamine N-acyltransferase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>22</bold></td><td align="center" rowspan="1" colspan="1">ubiA</td><td align="left" rowspan="1" colspan="1">4-hydroxybenzoate octaprenyltransferase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Transmembrane</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>23</bold></td><td align="center" rowspan="1" colspan="1">ubiX</td><td align="left" rowspan="1" colspan="1">3-polyprenyl-4-hydroxybenzoate decarboxylase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>24</bold></td><td align="center" rowspan="1" colspan="1">gmhA</td><td align="left" rowspan="1" colspan="1">Phosphoheptose isomerase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>25</bold></td><td align="center" rowspan="1" colspan="1">pdxJ</td><td align="left" rowspan="1" colspan="1">pyridoxine 5'-phosphate synthase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>26</bold></td><td align="center" rowspan="1" colspan="1">glmU</td><td align="left" rowspan="1" colspan="1">UDP-N-acetylglucosamine diphosphorylase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>27</bold></td><td align="center" rowspan="1" colspan="1">queF</td><td align="left" rowspan="1" colspan="1">NADPH-dependent 7-cyano-7-deazaguanine reductase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>28</bold></td><td align="center" rowspan="1" colspan="1">cobA</td><td align="left" rowspan="1" colspan="1">Cob(l)alaminadenosyltransferase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">Choke Point</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>29</bold></td><td align="center" rowspan="1" colspan="1">mqnC</td><td align="left" rowspan="1" colspan="1">Dehypoxanthinefutalosinecyclase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>30</bold></td><td align="center" rowspan="1" colspan="1">kamA</td><td align="left" rowspan="1" colspan="1">L-lysine 2,3-aminomutase</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>31</bold></td><td align="center" rowspan="1" colspan="1">cheR</td><td align="left" rowspan="1" colspan="1">Methylase of chemotaxis methyl-accepting protein</td><td align="center" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">Cytoplasmic</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>32</bold></td><td align="center" rowspan="1" colspan="1">fliN</td><td align="left" rowspan="1" colspan="1">Flagellar motor switch protein</td><td align="center" rowspan="1" colspan="1">Non- Enzyme</td><td align="center" rowspan="1" colspan="1">Transmembrane</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>33</bold></td><td align="center" rowspan="1" colspan="1">mcp</td><td align="left" rowspan="1" colspan="1">MCP methylation inhibitor</td><td align="center" rowspan="1" colspan="1">Non- Enzyme</td><td align="center" rowspan="1" colspan="1">Transmembrane</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>34</bold></td><td align="center" rowspan="1" colspan="1">cheA</td><td align="left" rowspan="1" colspan="1">Two-component system sensor histidine kinase</td><td align="center" rowspan="1" colspan="1">Non- Enzyme</td><td align="center" rowspan="1" colspan="1">Transmembrane</td><td align="center" rowspan="1" colspan="1">NA</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec015"><title>Subcellular localization</title><p>Localization of 34 common drug targets in current study exposed that 29 drug targets are cytoplasmic and 5 are transmembrane proteins (<xref rid="pone.0221446.t002" ref-type="table">Table 2</xref>). The membrane proteins have the capability to act as useful vaccine drug targets against all strains of <italic>Leptospira</italic>. However, these transmembrane proteins are involved in lipid polysaccharide synthesis (kdtA), ubiquinone-terpenoid-quinone biosynthesis (ubiA), bacterial chemotaxis (fliN, cheA, mcp)as well as part of flagellar assembly (fliN) and two component system (mcp, cheA). These play an essential role in the survival and pathogenesis of <italic>Leptospira</italic>. Location of these drug targets is required in future to design drug or vaccine accordingly. Subcellular localization information of a drug target should complement with the pharmacological properties of lead molecules targeted to it, therefore, it is an important aspect in rational drug design.</p></sec><sec id="sec016"><title>Genome scale metabolic network reconstruction</title><p>Genome scale metabolic network of <italic>L</italic>. <italic>borgpetersenii</italic> serovar Hardjo-bovis str. L550 and <italic>L</italic>. <italic>interrogans</italic> serovar Copenhageni str. Fiocruz L1-130 were constructed successfully using Pathway Tools Software. Model of <italic>L</italic>. <italic>interrogans</italic> serovar Copenhageni str. Fiocruz L1-130 comprised 673 enzymes, 988 enzymatic reactions, 6 transport reactions, 133 pathways, 957 compounds, 37 tRNAs, 6 transporter and 3684 polypeptides (<xref ref-type="supplementary-material" rid="pone.0221446.s001">S1 SBML</xref>). Likewise, model of <italic>L</italic>. <italic>borgpetersenii</italic> serovar Hardjo-bovis str. L550 constructed with 141 pathways, 613 enzymes, 1099 enzymatic reactions, 5 transport reactions, 3290 polypeptides, 12 transporters and 1075 metabolites (<xref ref-type="supplementary-material" rid="pone.0221446.s002">S2 SBML</xref>). From the set of 34 drug target, 20 and 23 were shaped in reconstructed model of <italic>L</italic>. <italic>borgpetersenii</italic> serovar Hardjo-bovis str. L550 and <italic>L</italic>. <italic>interrogans</italic> serovar Copenhageni str. Fiocruz L1-130 respectively. These reconstructed models were used for choke point analysis.</p></sec><sec id="sec017"><title>Choke point analysis</title><p>Chokepoint enzymes are enzymes that catalyze a reaction which either uniquely consume a substrate or interestingly deliver a precise product. If an enzyme catalyzes at least one chokepoint reaction, it is classified as a promising drug target. Accordingly, we expect the hindrance of a protein that expends an exceptional substrate brings aggregation in the remarkable substrate. This may be conceivably harmful to the cell and restraint the compound that delivers one of a kind item which further leads to the starvation of special product [<xref rid="pone.0221446.ref032" ref-type="bibr">32</xref>&#x02013;<xref rid="pone.0221446.ref033" ref-type="bibr">33</xref>].</p><p>Pathway tool generated the report of choke point reactions for reconstructed model of <italic>L</italic>. <italic>interrogans</italic> serovar Copenhageni str. Fiocruz L1-130 and <italic>L</italic>. <italic>borgpetersenii</italic> serovar Hardjo-bovis str. L550. The report consists of choke point reactions on the consuming side as well as producing side. Target cobA (cob(I)yrinic acid a) and thiL (thiamine-phosphate kinase) is found as a choke enzyme in both the reconstructed genome scale metabolic model of Leptospiral strains (<xref rid="pone.0221446.t002" ref-type="table">Table 2</xref>). The cobA with an EC: 2.5.1.17 participated in cobalamin biosynthesis pathway. Pathogenic strains of <italic>Leptospira</italic> can&#x02019;t grow in the absence of cobalamin that&#x02019;s why it is an essential component of the Ellinghausen-McCullough-Johnson-Harris (EMJH) semi-synthetic selective medium [<xref rid="pone.0221446.ref049" ref-type="bibr">49</xref>&#x02013;<xref rid="pone.0221446.ref050" ref-type="bibr">50</xref>]. In contrast, gene thiL found to be important in conversion of thiamine monophosphate to thiamine pyrophosphate which is essential for pathogen survival [<xref rid="pone.0221446.ref052" ref-type="bibr">52</xref>]. Results of pathway tool were also validated with BioCyc server that shows cobA as choke point in most of the Leptospiral strain and thiL in <italic>L</italic>. <italic>mayottensis</italic> 200901122 and <italic>L</italic>. <italic>kmetyi</italic> serovar Malaysia str. Bejo-Iso9.</p></sec><sec id="sec018"><title>Sequence alignment, homology modelling and validation</title><p>Multiple sequence alignment was performed for cobA and thiL gene within the pathogenic <italic>Leptospira</italic> strain (<xref rid="pone.0221446.t001" ref-type="table">Table 1</xref>). The result showed conserved, semi conserved and dispersed amino acid residues. The semi-conserved residues were showen with dot and conserved with red star (<xref ref-type="supplementary-material" rid="pone.0221446.s003">S1</xref> and <xref ref-type="supplementary-material" rid="pone.0221446.s004">S2 Files</xref>). ESPript defined MSA of cobA showed the 10 &#x003b1;helix (9&#x003b1; + &#x003b7;), 10 &#x003b2;-sheets and 6 turns (TT) while 9 &#x003b1;helix (8&#x003b1; + &#x003b7;), 12 &#x003b2;-sheets and 7 turns (TT) were found in thiL. In addition, psiPred server validated the ESPript report for both the chokepoints. All these results were in agreement with each other for the secondary structure elements of cobA and thiL. Afterwards, 3D structure of thiL and cobA were modelled using <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/2YBQ_A?report=genbank&#x00026;log$=prottop&#x00026;blast_rank=1&#x00026;RID=K371GZ40014">2YBQ_A</ext-link> (Query Coverage: 88%, Identity: 39.36%) and <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/3C9R_A?report=genbank&#x00026;log$=prottop&#x00026;blast_rank=1&#x00026;RID=K371MMXW014">3C9R_A</ext-link> (Query Coverage: 88%, Identity: 30.32%) as template respectively (<xref ref-type="fig" rid="pone.0221446.g004">Fig 4</xref>). The quality of the modelled structures after energy minimization was evaluated on the UCLA SAVES server shown in <xref rid="pone.0221446.t003" ref-type="table">Table 3</xref>. CastP predicted the largest binding pocket of both modelled structures. Surface view of cobA is showing a deep binding pocket while thiL represented Gln23, Thr24, Asp25, Asp26, Asp39, Asp68, Arg140, Asp207, Thr209 and Asp210 as key residues in their binding pocket (<xref ref-type="fig" rid="pone.0221446.g004">Fig 4</xref>).</p><fig id="pone.0221446.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0221446.g004</object-id><label>Fig 4</label><caption><title>Active site prediction of thiL and cobA.</title><p>(A) Largest binding site of modelled structure of thiL (magenta color) showing the active site cleft (grey color). Key residues of binding pocket are highlighted with blue color while rests are shown in a box. (B) Likewise, surface view of binding pocket of cobA (green color) is very deep in comparison with thiL. Binding residues present in largest pocket of modelled protein is presented in orange color.</p></caption><graphic xlink:href="pone.0221446.g004"/></fig><table-wrap id="pone.0221446.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0221446.t003</object-id><label>Table 3</label><caption><title>Refinement and quality assessment of modelled structure of thiL and cobA.</title></caption><alternatives><graphic id="pone.0221446.t003g" xlink:href="pone.0221446.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1"><break/></th><th align="center" rowspan="2" colspan="1">Verify3D<break/></th><th align="left" rowspan="2" colspan="1">ERRAT<break/></th><th align="center" rowspan="2" colspan="1">PROVE<break/></th><th align="center" colspan="3" rowspan="1">PROCHECK</th><th align="center" rowspan="2" colspan="1">Prosa<break/>Z Score</th><th align="left" rowspan="2" colspan="1">QMEAN<break/></th></tr><tr><th align="center" rowspan="1" colspan="1">Favoured</th><th align="center" rowspan="1" colspan="1">Allowed</th><th align="center" rowspan="1" colspan="1">Disallowed</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1"><bold>thiL</bold></td><td align="center" rowspan="1" colspan="1">86.38% of the residues have<break/>averaged 3D-1D score &#x0003e; = 0.2<break/>Pass</td><td align="center" rowspan="1" colspan="1">84.1549</td><td align="center" rowspan="1" colspan="1">55 buried outlier protein atoms, 5.3% (Error)</td><td align="center" rowspan="1" colspan="1">289 (94.8%)</td><td align="center" rowspan="1" colspan="1">13 (4.3%)</td><td align="center" rowspan="1" colspan="1">3<break/>(1.0%)</td><td align="center" rowspan="1" colspan="1">-7.8</td><td align="center" rowspan="1" colspan="1">-2.26</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>cobA</bold></td><td align="center" rowspan="1" colspan="1">85.02% of the residues have<break/>averaged 3D-1D score &#x0003e; = 0.2<break/>Pass</td><td align="center" rowspan="1" colspan="1">95.935</td><td align="center" rowspan="1" colspan="1">2 7 buried outlier protein atoms, 3.4% (Error)</td><td align="center" rowspan="1" colspan="1">269 (97.1%)</td><td align="center" rowspan="1" colspan="1">7 (2.5%)</td><td align="center" rowspan="1" colspan="1">3<break/>(1.0%)</td><td align="center" rowspan="1" colspan="1">1 (0.4%)</td><td align="center" rowspan="1" colspan="1">-1.24</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec019"><title>Prioritization of drug targets</title><p>Putative drug targets were subjected for prioritization through network analysis, molecular complex detection and gene enrichment analysis (<xref ref-type="fig" rid="pone.0221446.g001">Fig 1</xref>). As mentioned, string app is restricted to generate protein-protein interaction network of <italic>L</italic>. <italic>borgpetersenii</italic> serovar Hardjo-bovis str. L550 and <italic>L</italic>. <italic>interrogans</italic> serovar Copenhageni str. Fiocruz L1-130. Network of <italic>L</italic>. <italic>borgpetersenii</italic> comprised of 38 nodes with 41 edges. Gene lpxD-2, kdsB-2 and lpxK demonstrated the most noteworthy degree followed by kdtA, lpxD-1, lpxB and lpxC with degree 6 (<xref rid="pone.0221446.t004" ref-type="table">Table 4</xref>; <xref ref-type="fig" rid="pone.0221446.g005">Fig 5A</xref>). Similarly, <italic>L</italic>. <italic>interrogans</italic> Copenhageni L1-130 had 41 nodes with 40 edges. Most astounding degree hub is observed for kdtA and lpxK followed by lpxD, lpxB, lpxC and lpxA (<xref rid="pone.0221446.t005" ref-type="table">Table 5</xref>; <xref ref-type="fig" rid="pone.0221446.g005">Fig 5C</xref>). Extension of these two networks, with all proteins of pathogen, stretched the estimation of best genes of the system and predicts with assurance the essential role of these genes for pathogen (Tables <xref rid="pone.0221446.t004" ref-type="table">4</xref> and <xref rid="pone.0221446.t005" ref-type="table">5</xref>). After network extension, degree of cheR increased from 0 to 91, fliN from 0 to 68, cobA from 0 to 35 and metX from 0 to 38 in case of <italic>L</italic>. <italic>borgpetersenii</italic> Hardjo-bovis L550 while degree of cheR increased from 4 to 76, fliN from 0 to 66, cob A from 4 to 47 and metX from 2 to 39 in case <italic>L</italic>. <italic>interrogans</italic> Copenhageni L1-130.</p><fig id="pone.0221446.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0221446.g005</object-id><label>Fig 5</label><caption><title>Network analysis and molecular function detection.</title><p>(A) &#x00026; (B) present the protein-protein interaction within the selected proteins of <italic>L</italic>. <italic>borgpetersenii</italic> serovar Hardjo-bovis str. L550 whereas (C) &#x00026; (D) denote the interacting partners of <italic>L</italic>. <italic>interrogans</italic> serovar Copenhageni str. Fiocruz L1-130. In PPI network, nodes denote protein and interaction between the 2 nodes denotes the edge. Significant MCODE cluster (B) and (D) denotes the genes which are involved in polysaccharide biosynthesis pathway.</p></caption><graphic xlink:href="pone.0221446.g005"/></fig><table-wrap id="pone.0221446.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0221446.t004</object-id><label>Table 4</label><caption><title>List of Interacting partners within selected proteins as well as within all proteins of <italic>L</italic>. <italic>borgpetersenii serovar Hardjo-bovis str</italic>. <italic>L550</italic>.</title></caption><alternatives><graphic id="pone.0221446.t004g" xlink:href="pone.0221446.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Proteins</th><th align="center" rowspan="1" colspan="1">Description</th><th align="center" rowspan="1" colspan="1">Interaction_selected Proteins</th><th align="center" rowspan="1" colspan="1">Interaction_All Proteins of Pathogen</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">lpxK</td><td align="left" rowspan="1" colspan="1">Tetraacyldisaccharide 4'-kinase</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">79</td></tr><tr><td align="center" rowspan="1" colspan="1">kdsB-2</td><td align="left" rowspan="1" colspan="1">3-deoxy-manno-octulosonate cytidylyltransferase</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">55</td></tr><tr><td align="center" rowspan="1" colspan="1">lpxD-2</td><td align="left" rowspan="1" colspan="1">UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">51</td></tr><tr><td align="center" rowspan="1" colspan="1">lpxC</td><td align="left" rowspan="1" colspan="1">UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">60</td></tr><tr><td align="center" rowspan="1" colspan="1">lpxB</td><td align="left" rowspan="1" colspan="1">Lipid-A-disaccharide synthase</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">76</td></tr><tr><td align="center" rowspan="1" colspan="1">lpxD-1</td><td align="left" rowspan="1" colspan="1">UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">73</td></tr><tr><td align="center" rowspan="1" colspan="1">kdtA</td><td align="left" rowspan="1" colspan="1">3-deoxy-D-manno-octulosonic-acid (KDO) transferase</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">79</td></tr><tr><td align="center" rowspan="1" colspan="1">ubiA</td><td align="left" rowspan="1" colspan="1">Prenyltransferase</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">46</td></tr><tr><td align="center" rowspan="1" colspan="1">ubiX</td><td align="left" rowspan="1" colspan="1">3-polyprenyl-4-hydroxybenzoate decarboxylase</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">51</td></tr><tr><td align="center" rowspan="1" colspan="1">ubiD</td><td align="left" rowspan="1" colspan="1">3-polyprenyl-4-hydroxybenzoate decarboxylase</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">34</td></tr><tr><td align="center" rowspan="1" colspan="1">ribC</td><td align="left" rowspan="1" colspan="1">Riboflavin synthase subunit alpha</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">17</td></tr><tr><td align="center" rowspan="1" colspan="1">rpoN</td><td align="left" rowspan="1" colspan="1">DNA-directed RNA polymerase sigma-54 subunit</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">71</td></tr><tr><td align="center" rowspan="1" colspan="1">thiH</td><td align="left" rowspan="1" colspan="1">Thiamine biosynthesis enzyme</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">41</td></tr><tr><td align="center" rowspan="1" colspan="1">thiL</td><td align="left" rowspan="1" colspan="1">Thiamine monophosphate kinase</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">23</td></tr><tr><td align="center" rowspan="1" colspan="1">panD</td><td align="left" rowspan="1" colspan="1">Aspartate alpha-decarboxylase</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">44</td></tr><tr><td align="center" rowspan="1" colspan="1">panC</td><td align="left" rowspan="1" colspan="1">Pantoate&#x02014;beta-alanine ligase</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">27</td></tr><tr><td align="center" rowspan="1" colspan="1">panB</td><td align="left" rowspan="1" colspan="1">3-methyl-2-oxobutanoate hydroxymethyltransferase</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">60</td></tr><tr><td align="center" rowspan="1" colspan="1">ribD</td><td align="left" rowspan="1" colspan="1">pyrimidine deaminase, riboflavin biosynthesis</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">56</td></tr><tr><td align="center" rowspan="1" colspan="1">hprK</td><td align="left" rowspan="1" colspan="1">HPr kinase/phosphorylase</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">39</td></tr><tr><td align="center" rowspan="1" colspan="1">pdxA</td><td align="left" rowspan="1" colspan="1">4-hydroxythreonine-4-phosphate dehydrogenase</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">66</td></tr><tr><td align="center" rowspan="1" colspan="1">pssA</td><td align="left" rowspan="1" colspan="1">CDP-diacylglycerol&#x02014;serine O-phosphatidyltransferase</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">41</td></tr><tr><td align="center" rowspan="1" colspan="1">LBL_4236</td><td align="left" rowspan="1" colspan="1">Lysine 2,3-aminomutase</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">39</td></tr><tr><td align="center" rowspan="1" colspan="1">LBL_1044</td><td align="left" rowspan="1" colspan="1">Lysine 2,3-aminomutase</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">39</td></tr><tr><td align="center" rowspan="1" colspan="1">pdxJ</td><td align="left" rowspan="1" colspan="1">Pyridoxine 5'-phosphate synthase</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">50</td></tr><tr><td align="center" rowspan="1" colspan="1">trpF</td><td align="left" rowspan="1" colspan="1">Phosphoribosylanthranilate isomerase</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">42</td></tr><tr><td align="center" rowspan="1" colspan="1">cysH-2</td><td align="left" rowspan="1" colspan="1">Sulfate adenylyltransferase subunit 2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">14</td></tr><tr><td align="center" rowspan="1" colspan="1">cysH-1</td><td align="left" rowspan="1" colspan="1">Phosphoadenylyl-sulfate reductase (thioredoxin)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">13</td></tr><tr><td align="center" rowspan="1" colspan="1">sufE</td><td align="left" rowspan="1" colspan="1">Fe-S metabolism protein</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">38</td></tr><tr><td align="center" rowspan="1" colspan="1">ccmF</td><td align="left" rowspan="1" colspan="1">Cytochrome c biogenesis protein</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">49</td></tr><tr><td align="center" rowspan="1" colspan="1">gshA</td><td align="left" rowspan="1" colspan="1">Gamma-glutamylcysteinesynthetase</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">25</td></tr><tr><td align="center" rowspan="1" colspan="1">gspF</td><td align="left" rowspan="1" colspan="1">Type II secretory pathway component, protein F</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">21</td></tr><tr><td align="center" rowspan="1" colspan="1">fliN-1</td><td align="left" rowspan="1" colspan="1">Endoflagellar motor switch protein</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">91</td></tr><tr><td align="center" rowspan="1" colspan="1">cobA</td><td align="left" rowspan="1" colspan="1">Cob(I)yrinic acid a,c-diamideadenosyltransferase</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">35</td></tr><tr><td align="center" rowspan="1" colspan="1">cheR</td><td align="left" rowspan="1" colspan="1">Methyltransferase of chemotaxis protein</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">68</td></tr><tr><td align="center" rowspan="1" colspan="1">aat</td><td align="left" rowspan="1" colspan="1">Leucyl/phenylalanyl-tRNA&#x02014;protein transferase</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">18</td></tr><tr><td align="center" rowspan="1" colspan="1">manA</td><td align="left" rowspan="1" colspan="1">Mannose-6-phosphate isomerase</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">18</td></tr><tr><td align="center" rowspan="1" colspan="1">gmhA</td><td align="left" rowspan="1" colspan="1">Phosphoheptose isomerase</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">17</td></tr><tr><td align="center" rowspan="1" colspan="1">metX</td><td align="left" rowspan="1" colspan="1">Homoserine O-acetyltransferase</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">11</td></tr></tbody></table></alternatives></table-wrap><table-wrap id="pone.0221446.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0221446.t005</object-id><label>Table 5</label><caption><title>List of Interacting partners within selected proteins as well as within all proteins of <italic>L</italic>. <italic>interrogans</italic> serovar Copenhageni str. Fiocruz L1-130.</title></caption><alternatives><graphic id="pone.0221446.t005g" xlink:href="pone.0221446.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Proteins</th><th align="center" rowspan="1" colspan="1">Description</th><th align="center" rowspan="1" colspan="1">Interaction_selected Proteins</th><th align="center" rowspan="1" colspan="1">Interaction_All Proteins of Pathogen</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">kdtA</td><td align="left" rowspan="1" colspan="1">3-deoxy-d-manno-octulosonic acid transferase</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">109</td></tr><tr><td align="center" rowspan="1" colspan="1">lpxK</td><td align="left" rowspan="1" colspan="1">Tetraacyldisaccharide 4'-kinase</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">57</td></tr><tr><td align="center" rowspan="1" colspan="1">lpxD</td><td align="left" rowspan="1" colspan="1">UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">70</td></tr><tr><td align="center" rowspan="1" colspan="1">lpxB</td><td align="left" rowspan="1" colspan="1">Lipid-a-disaccharide synthase protein</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">66</td></tr><tr><td align="center" rowspan="1" colspan="1">lpxC</td><td align="left" rowspan="1" colspan="1">UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">70</td></tr><tr><td align="center" rowspan="1" colspan="1">lpxA</td><td align="left" rowspan="1" colspan="1">UDP-N-acetylglucosamine acyltransferase</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">76</td></tr><tr><td align="center" rowspan="1" colspan="1">cysI</td><td align="left" rowspan="1" colspan="1">Sulfite reductase subunit beta</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">40</td></tr><tr><td align="center" rowspan="1" colspan="1">cheR</td><td align="left" rowspan="1" colspan="1">Chemotaxis protein methyltransferase</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">76</td></tr><tr><td align="center" rowspan="1" colspan="1">cobA</td><td align="left" rowspan="1" colspan="1">Uroporphyrinogen-III C-methyltransferase</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">47</td></tr><tr><td align="center" rowspan="1" colspan="1">pssA</td><td align="left" rowspan="1" colspan="1">Phosphatidylserine synthase</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">37</td></tr><tr><td align="center" rowspan="1" colspan="1">cysH</td><td align="left" rowspan="1" colspan="1">Phosphoadenosine phosphosulphate reductase</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">32</td></tr><tr><td align="center" rowspan="1" colspan="1">cysD</td><td align="left" rowspan="1" colspan="1">Sulfate adenylyltransferase subunit 2</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">32</td></tr><tr><td align="center" rowspan="1" colspan="1">panD</td><td align="left" rowspan="1" colspan="1">Aspartate alpha-decarboxylase</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">36</td></tr><tr><td align="center" rowspan="1" colspan="1">aer</td><td align="left" rowspan="1" colspan="1">Chemotaxis protein</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">9</td></tr><tr><td align="center" rowspan="1" colspan="1">metX</td><td align="left" rowspan="1" colspan="1">Homoserine O-acetyltransferase</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">39</td></tr><tr><td align="center" rowspan="1" colspan="1">mcp</td><td align="left" rowspan="1" colspan="1">Chemotaxis protein</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">84</td></tr><tr><td align="center" rowspan="1" colspan="1">wecG</td><td align="left" rowspan="1" colspan="1">UDP-n-acetyl-d-mannosamine transferase</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">48</td></tr><tr><td align="center" rowspan="1" colspan="1">panB</td><td align="left" rowspan="1" colspan="1">3-methyl-2-oxobutanoate hydroxymethyltransferase</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">39</td></tr><tr><td align="center" rowspan="1" colspan="1">panC</td><td align="left" rowspan="1" colspan="1">Pantoate&#x02014;beta-alanine ligase</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">66</td></tr><tr><td align="center" rowspan="1" colspan="1">ubiA</td><td align="left" rowspan="1" colspan="1">Prenyltransferase</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">50</td></tr><tr><td align="center" rowspan="1" colspan="1">thiL</td><td align="left" rowspan="1" colspan="1">Thiamine-monophosphate kinase protein</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">33</td></tr><tr><td align="center" rowspan="1" colspan="1">rpoN</td><td align="left" rowspan="1" colspan="1">RNA polymerase sigma-54 factor</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">119</td></tr><tr><td align="center" rowspan="1" colspan="1">pdxA</td><td align="left" rowspan="1" colspan="1">Pyridoxal phosphate biosynthesis protein</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">28</td></tr><tr><td align="center" rowspan="1" colspan="1">glnD</td><td align="left" rowspan="1" colspan="1">Protein-PII uridylyltransferase</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">28</td></tr><tr><td align="center" rowspan="1" colspan="1">mviN</td><td align="left" rowspan="1" colspan="1">hHypothetical protein</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">52</td></tr><tr><td align="center" rowspan="1" colspan="1">trpF</td><td align="left" rowspan="1" colspan="1">N-(5'-phosphoribosyl)anthranilate isomerase</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">44</td></tr><tr><td align="center" rowspan="1" colspan="1">rffE</td><td align="left" rowspan="1" colspan="1">UDP-N-acetylglucosamine 2-epimerase</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">106</td></tr><tr><td align="center" rowspan="1" colspan="1">ubiX</td><td align="left" rowspan="1" colspan="1">3-octaprenyl-4-hydroxybenzoate carboxy-lyase</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">30</td></tr><tr><td align="center" rowspan="1" colspan="1">yoaA</td><td align="left" rowspan="1" colspan="1">ATP-dependent helicase</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">58</td></tr><tr><td align="center" rowspan="1" colspan="1">pdxJ</td><td align="left" rowspan="1" colspan="1">Pyridoxine 5'-phosphate synthase</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">37</td></tr><tr><td align="center" rowspan="1" colspan="1">manA</td><td align="left" rowspan="1" colspan="1">Mannose-6-phosphate isomerase</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">24</td></tr><tr><td align="center" rowspan="1" colspan="1">sanA</td><td align="left" rowspan="1" colspan="1">Vancomycin resistance protein</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="center" rowspan="1" colspan="1">aat</td><td align="left" rowspan="1" colspan="1">Leucyl/phenylalanyl-tRNA&#x02014;protein transferase</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">24</td></tr><tr><td align="center" rowspan="1" colspan="1">kdpA</td><td align="left" rowspan="1" colspan="1">Potassium-transporting ATPase subunit A</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">21</td></tr><tr><td align="center" rowspan="1" colspan="1">tag</td><td align="left" rowspan="1" colspan="1">3-methyl-adenine DNA glycosylase I</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td align="center" rowspan="1" colspan="1">helA</td><td align="left" rowspan="1" colspan="1">Heavy metal efflux pump</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">8</td></tr><tr><td align="center" rowspan="1" colspan="1">gspF</td><td align="left" rowspan="1" colspan="1">General secretory pathway protein F</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">20</td></tr><tr><td align="center" rowspan="1" colspan="1">gshA</td><td align="left" rowspan="1" colspan="1">Gamma-glutamylcysteine synthetase</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">11</td></tr><tr><td align="center" rowspan="1" colspan="1">ccmF</td><td align="left" rowspan="1" colspan="1">Cytochrome C biogenesis protein</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">18</td></tr><tr><td align="center" rowspan="1" colspan="1">kamA</td><td align="left" rowspan="1" colspan="1">L-lysine 2,3-aminomutase</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">12</td></tr><tr><td align="center" rowspan="1" colspan="1">fliN</td><td align="left" rowspan="1" colspan="1">Flagellar motor switch protein</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">66</td></tr></tbody></table></alternatives></table-wrap><p>Molecular code detection produces one significant cluster with MCODE score = 15.733 for <italic>L</italic>. <italic>borgpetersenii</italic> Hardjo-bovis L550. It comprised 16 hubs associated through 118 edges. All 16 hubs are similarly connecting with one another with the degree of 13 to 15. Gene kdtA is found to be the seed protein of PPI network (<xref ref-type="fig" rid="pone.0221446.g005">Fig 5B</xref>). Gene enrichment analysis displayed lpxD-2, kdsB2, lpxC, lpxB, kdtA, lpxK, lpxD-1 and manA. These are markedly enriched in positive regulation of lipopolysaccharide biosynthesis while most of the genes are involved in metabolic pathways. Similarly, <italic>L</italic>. <italic>interrogans</italic> Copenhageni Fiocruz L1-130 module 1 obtained MCODE score = 14.857 with 15 nodes that interconnected with 104 edges. Gene kdsB is the seed of network which is connected to 13 other genes of the network (<xref ref-type="fig" rid="pone.0221446.g005">Fig 5D</xref>). Gene enrichment displayed 4 genes fliN, cheR, mcp and aer. These genes are part of two component system and involved in bacterial chemotaxis. The gene ontology analysis indicated that selected essential genes of both the pathogens are important part of metabolic pathways and lipopolysaccharide biosynthesis (<xref ref-type="fig" rid="pone.0221446.g005">Fig 5</xref>). Extended network added ribB, ribC, cysl, cysH, cysD, cobA and cysG genes which are responsible for riboflavin biosynthesis, microbial metabolism in diverse environment, sulfur metabolism porhyrin and cholorophyll metabolism (Tables <xref rid="pone.0221446.t004" ref-type="table">4</xref> and <xref rid="pone.0221446.t005" ref-type="table">5</xref>).</p></sec><sec id="sec020"><title>Comparative analysis</title><p>Comparison between both the networks showed 37 putative targets having the degree &#x02265;30 among which 18 hubs are observed to be common in both pathogens. Among the hub proteins, 16 are also shortlisted from the set of 34 common putative drug targets. Multiple sequence alignment revealed that these hub targets are conserved in at least 10 strains of pathogen. Among these common hub proteins, 8 are novel in at least 10 strains, 5 are virulent while 2 are novel as well as common drug targets (Figs <xref ref-type="fig" rid="pone.0221446.g006">6</xref> and <xref ref-type="fig" rid="pone.0221446.g007">7</xref>). Hence, these 8 proteins lpxB, lpxK, kdtA, fliN, cobA, metX, thiL and ubiA are proposed as putative drug targets in the present study, as absence of these proteins would affect the survival and pathogenicity of pathogen. However, target proteins lpxB, lpxK, kdtA, cobA, metX and ubiA were previously reported in the study of Amineni <italic>et al</italic>., 2010 for 2 pathogenic strains of <italic>Leptospira</italic> through subtractive genomic analysis but fliN and thiL are novel targets which are reported first time in our study [<xref rid="pone.0221446.ref020" ref-type="bibr">20</xref>] (<xref ref-type="fig" rid="pone.0221446.g008">Fig 8</xref>).</p><fig id="pone.0221446.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0221446.g006</object-id><label>Fig 6</label><caption><title>Druggability analysis of proteins of <italic>Leptospira</italic> strains.</title><p>X axis consists of number of strains and Y axis contains non-homolog gut flora proteins present in <italic>Leptospira</italic> strains. Right mark denotes the presence of novel target in each strain. Gene product lpxK, lpxB and cysD found to be novel in all strains of pathogen whereas in 16 out of 15 strains, kdtA, fliN, rpoN and queF are seen to be novel.</p></caption><graphic xlink:href="pone.0221446.g006"/></fig><fig id="pone.0221446.g007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0221446.g007</object-id><label>Fig 7</label><caption><title>Virulent analysis of proteins of <italic>Leptospira</italic> strains.</title><p>X axis consists of number of strains and Y axis contains non-homolog gut flora proteins present in <italic>Leptospira</italic> strains. Right mark denotes the presence of virulent target in each strain. Gene product lpxK and lpxB found to be virulent in all strains of pathogen whereas in 16 out of 15 strains, kdtA and rpoN are seen to be virulent. Protein fliN is important for virulence in 14 strains of <italic>Leptospira</italic>.</p></caption><graphic xlink:href="pone.0221446.g007"/></fig><fig id="pone.0221446.g008" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0221446.g008</object-id><label>Fig 8</label><caption><title>Comparative analysis of essential proteins.</title><p>Comparative analysis revealed 37 genes are essential. Among these, 16 are common in all strains of <italic>Leptospira</italic> from which 8 are found to be novel. From novel targets of <italic>Leptospira</italic>, 2 are acting as choke points and fliN protein is virulent in nature.</p></caption><graphic xlink:href="pone.0221446.g008"/></fig><p>The functional importance of the target candidates and the pathways involved are discussed here. As mentioned, proposed 8 drug targets majorly belong to 7 essential pathogen specific pathways. Amphipathic lipopolysaccharides are outer cell wall surface antigen of <italic>Leptospira</italic> and actively participate in virulence and antibiotic sensitivity [<xref rid="pone.0221446.ref053" ref-type="bibr">53</xref>&#x02013;<xref rid="pone.0221446.ref054" ref-type="bibr">54</xref>]. Lipopolysaccharides also act as primary barrier of pathogen and maintain the osmolarity of the gram negative cell. Inhibitor targeting lpxB, lpxK and kdtA proteins of outer membrane would affect the formation of primary barrier and alter the osmotic environment of pathogenic strains. This could be helpful to cure the leptospiral infections successfully. Taylor <italic>et al</italic>., 2008 and Raetz <italic>et al</italic>., 2002 also reported the proteins of this pathway as an efficient drug targets in other bacterial pathogens [<xref rid="pone.0221446.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0221446.ref055" ref-type="bibr">55</xref>&#x02013;<xref rid="pone.0221446.ref056" ref-type="bibr">56</xref>].</p><p>One of the central and defining reasons of increasing prevalence rate of Leptospirosis is the capability of the pathogenic strains to switch their flagellar motility for highly effective translocation via viscous substrates and tissues that permits access to far-away host niches [<xref rid="pone.0221446.ref057" ref-type="bibr">57</xref>]. Flagellar motor protein consists of three proteins among which fliN is one of major protein of flagellar motor switch system present in the basal body and interacts with chemotaxis proteins to define the translational and rotational motion of flagella [<xref rid="pone.0221446.ref049" ref-type="bibr">49</xref>,<xref rid="pone.0221446.ref050" ref-type="bibr">50</xref>]. Liao <italic>et al</italic>., 2009 showed inactivation of fliN gene that affects the rotative motion and migration in liquid and semi-solid medium respectively [<xref rid="pone.0221446.ref058" ref-type="bibr">58</xref>]. Hence, these complex set of genes involved in endoflagellum and its basal rotor system formation play critical role in the motility and virulence to cause Leptospirosis.</p><p>Target metX involved in methionine biosynthesis is found to be essential in all strains [<xref rid="pone.0221446.ref059" ref-type="bibr">59</xref>]. It is a proteinogenic as well as a component of S-adenosyl methionine which acts as a main methyl group carrier in cell. In most of the organisms including bacteria, it plays an important role in initiation of translation. Saint-Macary <italic>et al</italic>., 2015 reported that biosynthesis of methionine is essential for infection of <italic>M</italic>. <italic>oryzae</italic> [<xref rid="pone.0221446.ref060" ref-type="bibr">60</xref>]. Target cobA of cobalamin biosynthesis is present in chromosome I and also plays an essential role in the synthesis of vitamin-B12. Previous experimental evidence showed that vitamin B12 lacking growth medium was unable to grow the <italic>L</italic>. <italic>interrogans</italic> [<xref rid="pone.0221446.ref050" ref-type="bibr">50</xref>]. Thiamine monophosphate kinase (thiL) is an enzyme that catalyzes the thiamine monophosphate and converts it into thiamine pyrophosphate which is an essential cofactor in all living organism including <italic>Leptospira</italic> spp. Bian <italic>et al</italic>., 2011 discovered that to regulate the ABC transporters, riboswitches restricted to interact first with thiamine pyrophosphates due to which pathogen failed to grow in insufficient environment of thiamine pyrophosphate [<xref rid="pone.0221446.ref052" ref-type="bibr">52</xref>].</p><p>Thus, the proposed hub genes through the computational approach herein, support to find out broad spectrum drug targets that would be effective against pathogenic strain of <italic>Leptospira</italic> species. Although, the significance level of these putative targets need to be validated through experimental approach to ensure them as real one and can be the best against pathogenic strains <italic>of Leptospira</italic>.</p></sec></sec><sec sec-type="conclusions" id="sec021"><title>Conclusion</title><p>In the post genomic era, drug designing and discovery method is changing earlier established viewpoints. It routinely reorganizes the drug discovery method by incorporating vast data encrypted in our genome. We have performed subtractive genomic and comparative genomics analyses with network analysis of 16 pathogenic strains of <italic>Leptospira</italic> and identified 8 common drug targets that can be potential targets for drug designing and vaccine development. Moreover, many of the recognized drug targets have been observed to play a key role in the essential metabolic pathways, lipid biosynthesis, flagellar motor protein system and Bacterial chemotaxis. Among these targets, cobA and thiL also found as potent drug targets during genome scale metabolic reconstruction and choke point analysis. An efficient way to develop drugs against these targets would be substantially positive to diminish the threats of serious leptospirosis. However, these targets should be corroborated by further laboratory research for their role in inhibiting the growth and affecting the virulence of pathogens. Genome scale metabolic model of <italic>Leptospira</italic> would be useful in future for the basis of in silico gene knockout studies. Determination of qualitative tertiary structure and acknowledgment of functionally critical residues of these putative drug targets would be more effective in future for identification of novel leads and its optimization through <italic>in silico</italic> approaches like protein-ligand docking, free energy calculation and molecular dynamic simulations to design new anti-leptospiral drug against leptospirosis.</p></sec><sec sec-type="supplementary-material" id="sec022"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0221446.s001"><label>S1 SBML</label><caption><title>Genome scale metabolic network reconstruction of <italic>L</italic>.<italic>interrogans</italic> serovar Copenhageni str. Fiocruz L1-130.</title><p>(RAR)</p></caption><media xlink:href="pone.0221446.s001.rar"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0221446.s002"><label>S2 SBML</label><caption><title>Genome scale metabolic network reconstruction of <italic>L</italic>.<italic>borgpetersenii</italic> serovar Hardjo-bovis str. L550.</title><p>(RAR)</p></caption><media xlink:href="pone.0221446.s002.rar"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0221446.s003"><label>S1 File</label><caption><title>Multiple sequence alignment of thiL.</title><p>(DOCX)</p></caption><media xlink:href="pone.0221446.s003.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0221446.s004"><label>S2 File</label><caption><title>Multiple sequence alignment of cobA.</title><p>(DOCX)</p></caption><media xlink:href="pone.0221446.s004.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>Authors highly acknowledge Indian Council of Medical Research for supporting facilities to carry out the research work in Biomedical Informatics Centre, National Institute of Pathology, New Delhi vide RFC No. BIC/NTF/1/2013-2014 dated 18/02/2013.</p></ack><ref-list><title>References</title><ref id="pone.0221446.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Fair</surname><given-names>RJ</given-names></name>, <name><surname>Tor</surname><given-names>Y</given-names></name>. <article-title>Antibiotics and Bacterial Resistance in the 21st Century</article-title>. <source>Perspect Med Chem</source>. <year>2014</year>
<month>8</month>
<day>28</day>;<volume>6</volume>:<fpage>25</fpage>&#x02013;<lpage>64</lpage>.</mixed-citation></ref><ref id="pone.0221446.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Costa</surname><given-names>F</given-names></name>, <name><surname>Hagan</surname><given-names>JE</given-names></name>, <name><surname>Calcagno</surname><given-names>J</given-names></name>, <name><surname>Kane</surname><given-names>M</given-names></name>, <name><surname>Torgerson</surname><given-names>P</given-names></name>, <name><surname>Martinez-Silveira</surname><given-names>MS</given-names></name>, <etal>et al</etal>
<article-title>Global Morbidity and Mortality of Leptospirosis: A Systematic Review</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2015</year>
<month>9</month>
<day>17</day>;<volume>9</volume>(<issue>9</issue>):<fpage>e0003898</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0003898</pub-id>
<?supplied-pmid 26379143?><pub-id pub-id-type="pmid">26379143</pub-id></mixed-citation></ref><ref id="pone.0221446.ref003"><label>3</label><mixed-citation publication-type="book"><name><surname>Haake</surname><given-names>DA</given-names></name>, <name><surname>Levett</surname><given-names>PN</given-names></name>. <chapter-title>Leptospirosis in Humans</chapter-title> In: <name><surname>Adler</surname><given-names>B</given-names></name>, editor. <source>Leptospira and Leptospirosis</source> [Internet]. <publisher-loc>Berlin, Heidelberg</publisher-loc>: <publisher-name>Springer Berlin Heidelberg</publisher-name>; <year>2015</year> [cited 2019 Apr 6]. p. <fpage>65</fpage>&#x02013;<lpage>97</lpage>. (Current Topics in Microbiology and Immunology). Available from: <pub-id pub-id-type="doi">10.1007/978-3-662-45059-8_5</pub-id></mixed-citation></ref><ref id="pone.0221446.ref004"><label>4</label><mixed-citation publication-type="journal"><article-title>Leptospirosis worldwide, 1999</article-title>. <source>Releve Epidemiol Hebd</source>. <year>1999</year>
<month>7</month>
<day>23</day>;<volume>74</volume>(<issue>29</issue>):<fpage>237</fpage>&#x02013;<lpage>42</lpage>.</mixed-citation></ref><ref id="pone.0221446.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Pal</surname><given-names>M</given-names></name>, <name><surname>Hadush</surname><given-names>A</given-names></name>. <article-title>Leptospirosis: An Infectious Emerging Waterborne Zoonosis of Global Significance</article-title>. <source>Air Water Borne Dis</source>. <year>2017</year>
<month>3</month>
<day>15</day>;<volume>6</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>4</lpage>.</mixed-citation></ref><ref id="pone.0221446.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Victoriano</surname><given-names>AFB</given-names></name>, <name><surname>Smythe</surname><given-names>LD</given-names></name>, <name><surname>Gloriani-Barzaga</surname><given-names>N</given-names></name>, <name><surname>Cavinta</surname><given-names>LL</given-names></name>, <name><surname>Kasai</surname><given-names>T</given-names></name>, <name><surname>Limpakarnjanarat</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Leptospirosis in the Asia Pacific region</article-title>. <source>BMC Infect Dis</source>. <year>2009</year>
<month>9</month>
<day>4</day>;<volume>9</volume>(<issue>1</issue>):<fpage>147</fpage>.<pub-id pub-id-type="pmid">19732423</pub-id></mixed-citation></ref><ref id="pone.0221446.ref007"><label>7</label><mixed-citation publication-type="other">WHO Western Pacific | World Health Organization [Internet]. [cited 2019 May 5]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/westernpacific">https://www.who.int/westernpacific</ext-link></mixed-citation></ref><ref id="pone.0221446.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Izurieta</surname><given-names>R</given-names></name>, <name><surname>Galwankar</surname><given-names>S</given-names></name>, <name><surname>Clem</surname><given-names>A</given-names></name>. <article-title>Leptospirosis: The &#x0201c;mysterious&#x0201d; mimic</article-title>. <source>J Emerg Trauma Shock</source>. <year>2008</year>
<month>1</month>
<day>1</day>;<volume>1</volume>(<issue>1</issue>):<fpage>21</fpage>
<pub-id pub-id-type="doi">10.4103/0974-2700.40573</pub-id>
<?supplied-pmid 19561939?><pub-id pub-id-type="pmid">19561939</pub-id></mixed-citation></ref><ref id="pone.0221446.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Fernandes</surname><given-names>LGV</given-names></name>, <name><surname>Vieira</surname><given-names>ML</given-names></name>, <name><surname>Kirchgatter</surname><given-names>K</given-names></name>, <name><surname>Alves</surname><given-names>IJ</given-names></name>, <name><surname>Morais</surname><given-names>ZM de</given-names></name>, <name><surname>Vasconcellos</surname><given-names>SA</given-names></name>, <etal>et al</etal>
<article-title>OmpL1 Is an Extracellular Matrix- and Plasminogen-Interacting Protein of Leptospira spp</article-title>. <source>Infect Immun</source>. <year>2012</year>
<month>10</month>
<day>1</day>;<volume>80</volume>(<issue>10</issue>):<fpage>3679</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00474-12</pub-id>
<?supplied-pmid 22802342?><pub-id pub-id-type="pmid">22802342</pub-id></mixed-citation></ref><ref id="pone.0221446.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Plank</surname><given-names>R</given-names></name>, <name><surname>Dean</surname><given-names>D</given-names></name>. <article-title>Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humans</article-title>. <source>Microbes Infect</source>. <year>2000</year>
<month>8</month>
<day>1</day>;<volume>2</volume>(<issue>10</issue>):<fpage>1265</fpage>&#x02013;<lpage>76</lpage>. <?supplied-pmid 11008116?><pub-id pub-id-type="pmid">11008116</pub-id></mixed-citation></ref><ref id="pone.0221446.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Sethi</surname><given-names>S</given-names></name>, <name><surname>Sharma</surname><given-names>N</given-names></name>, <name><surname>Kakkar</surname><given-names>N</given-names></name>, <name><surname>Taneja</surname><given-names>J</given-names></name>, <name><surname>Chatterjee</surname><given-names>SS</given-names></name>, <name><surname>Banga</surname><given-names>SS</given-names></name>, <etal>et al</etal>
<article-title>Increasing Trends of Leptospirosis in Northern India: A Clinico-Epidemiological Study</article-title>. <source>PLoS Negl Trop Dis</source> [Internet]. <year>2010</year>
<month>1</month>
<day>12</day> [cited 2019 May 5];<volume>4</volume>(<issue>1</issue>). Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797087/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797087/</ext-link></mixed-citation></ref><ref id="pone.0221446.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Dhanze</surname><given-names>H</given-names></name>, <name><surname>Kumar</surname><given-names>S</given-names></name>, <name><surname>Mane</surname><given-names>B</given-names></name>. <article-title>Epidemiology of leptospirosis: an Indian perspective</article-title>. <source>J Foodborne Zoonotic Dis</source>. <year>2013</year>
<month>9</month>
<day>30</day>;<volume>1</volume>:<fpage>6</fpage>&#x02013;<lpage>13</lpage>.</mixed-citation></ref><ref id="pone.0221446.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Sambasiva</surname><given-names>RR</given-names></name>, <name><surname>Naveen</surname><given-names>G</given-names></name>, <name><surname>P</surname><given-names>B</given-names></name>, <name><surname>Agarwal</surname><given-names>SK</given-names></name>. <article-title>Leptospirosis in India and the rest of the world</article-title>. <source>Braz J Infect Dis Off Publ Braz Soc Infect Dis</source>. <year>2003</year>
<month>6</month>;<volume>7</volume>(<issue>3</issue>):<fpage>178</fpage>&#x02013;<lpage>93</lpage>.</mixed-citation></ref><ref id="pone.0221446.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Taylor</surname><given-names>J</given-names></name>, <name><surname>Goyle</surname><given-names>A</given-names></name>. <article-title>Leptospirosis in Andamans</article-title>. <source>Indian J Nedical Res</source>. <year>1931</year>;<volume>20</volume>:<fpage>55</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="pone.0221446.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Sivaprakasam</surname><given-names>V</given-names></name>, <name><surname>Zochowski</surname><given-names>WJ</given-names></name>, <name><surname>Palmer</surname><given-names>MF</given-names></name>. <article-title>Clinical spectrum of severe leptospirosis in the UK</article-title>. <source>JMM Case Rep [Internet]</source>. <year>2014</year> [cited 2019 Apr 6];<volume>1</volume>(<issue>4</issue>). Available from: <ext-link ext-link-type="uri" xlink:href="https://jmmcr.microbiologyresearch.org/content/journal/jmmcr/10.1099/jmmcr.0.000003">https://jmmcr.microbiologyresearch.org/content/journal/jmmcr/10.1099/jmmcr.0.000003</ext-link></mixed-citation></ref><ref id="pone.0221446.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Jin</surname><given-names>L</given-names></name>, <name><surname>W&#x00119;grzyn</surname><given-names>A</given-names></name>. <article-title>Leptospirosis vaccines</article-title>. <source>Microb Cell Factories</source>. <year>2007</year>
<month>12</month>
<day>11</day>;<volume>6</volume>(<issue>1</issue>):<fpage>39</fpage>.</mixed-citation></ref><ref id="pone.0221446.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Levett</surname><given-names>PN</given-names></name>. <article-title>Leptospirosis</article-title>. <source>Clin Microbiol Rev</source>. <year>2001</year>
<month>4</month>
<day>1</day>;<volume>14</volume>(<issue>2</issue>):<fpage>296</fpage>&#x02013;<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.14.2.296-326.2001</pub-id>
<?supplied-pmid 11292640?><pub-id pub-id-type="pmid">11292640</pub-id></mixed-citation></ref><ref id="pone.0221446.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Phimda</surname><given-names>K</given-names></name>, <name><surname>Hoontrakul</surname><given-names>S</given-names></name>, <name><surname>Suttinont</surname><given-names>C</given-names></name>, <name><surname>Chareonwat</surname><given-names>S</given-names></name>, <name><surname>Losuwanaluk</surname><given-names>K</given-names></name>, <name><surname>Chueasuwanchai</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Doxycycline versus Azithromycin for Treatment of Leptospirosis and Scrub Typhus</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2007</year>
<month>9</month>
<day>1</day>;<volume>51</volume>(<issue>9</issue>):<fpage>3259</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00508-07</pub-id>
<?supplied-pmid 17638700?><pub-id pub-id-type="pmid">17638700</pub-id></mixed-citation></ref><ref id="pone.0221446.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Gamberini</surname><given-names>M</given-names></name>, <name><surname>G&#x000f3;mez</surname><given-names>RM</given-names></name>, <name><surname>Atzingen</surname><given-names>MV</given-names></name>, <name><surname>Martins</surname><given-names>EAL</given-names></name>, <name><surname>Vasconcellos</surname><given-names>SA</given-names></name>, <name><surname>Romero</surname><given-names>EC</given-names></name>, <etal>et al</etal>
<article-title>Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis</article-title>. <source>FEMS Microbiol Lett</source>. <year>2005</year>
<month>3</month>
<day>1</day>;<volume>244</volume>(<issue>2</issue>):<fpage>305</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.femsle.2005.02.004</pub-id>
<?supplied-pmid 15766783?><pub-id pub-id-type="pmid">15766783</pub-id></mixed-citation></ref><ref id="pone.0221446.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Amineni</surname><given-names>U</given-names></name>, <name><surname>Pradhan</surname><given-names>D</given-names></name>, <name><surname>Marisetty</surname><given-names>H</given-names></name>. <article-title>In silico identification of common putative drug targets in Leptospira interrogans</article-title>. <source>J Chem Biol</source>. <year>2010</year>
<month>5</month>
<day>14</day>;<volume>3</volume>(<issue>4</issue>):<fpage>165</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1007/s12154-010-0039-1</pub-id>
<?supplied-pmid 21572503?><pub-id pub-id-type="pmid">21572503</pub-id></mixed-citation></ref><ref id="pone.0221446.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Fouts</surname><given-names>DE</given-names></name>, <name><surname>Matthias</surname><given-names>MA</given-names></name>, <name><surname>Adhikarla</surname><given-names>H</given-names></name>, <name><surname>Adler</surname><given-names>B</given-names></name>, <name><surname>Amorim-Santos</surname><given-names>L</given-names></name>, <name><surname>Berg</surname><given-names>DE</given-names></name>, <etal>et al</etal>
<article-title>What Makes a Bacterial Species Pathogenic?:Comparative Genomic Analysis of the Genus Leptospira</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2016</year>
<month>2</month>
<day>18</day>;<volume>10</volume>(<issue>2</issue>):<fpage>e0004403</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0004403</pub-id>
<?supplied-pmid 26890609?><pub-id pub-id-type="pmid">26890609</pub-id></mixed-citation></ref><ref id="pone.0221446.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Caimi</surname><given-names>K</given-names></name>, <name><surname>Repetto</surname><given-names>SA</given-names></name>, <name><surname>Varni</surname><given-names>V</given-names></name>, <name><surname>Ruybal</surname><given-names>P</given-names></name>. <article-title>Leptospira species molecular epidemiology in the genomic era</article-title>. <source>Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis</source>. <year>2017</year>;<volume>54</volume>:<fpage>478</fpage>&#x02013;<lpage>85</lpage>.</mixed-citation></ref><ref id="pone.0221446.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Gupta</surname><given-names>R</given-names></name>, <name><surname>Pradhan</surname><given-names>D</given-names></name>, <name><surname>Jain</surname><given-names>AK</given-names></name>, <name><surname>Rai</surname><given-names>CS</given-names></name>. <article-title>TiD: Standalone software for mining putative drug targets from bacterial proteome</article-title>. <source>Genomics</source>. <year>2017</year>
<month>1</month>
<day>1</day>;<volume>109</volume>(<issue>1</issue>):<fpage>51</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygeno.2016.11.005</pub-id>
<?supplied-pmid 27856224?><pub-id pub-id-type="pmid">27856224</pub-id></mixed-citation></ref><ref id="pone.0221446.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Kanehisa</surname><given-names>M</given-names></name>, <name><surname>Sato</surname><given-names>Y</given-names></name>, <name><surname>Kawashima</surname><given-names>M</given-names></name>, <name><surname>Furumichi</surname><given-names>M</given-names></name>, <name><surname>Tanabe</surname><given-names>M</given-names></name>. <article-title>KEGG as a reference resource for gene and protein annotation</article-title>. <source>Nucleic Acids Res</source>. <year>2016</year>
<month>1</month>
<day>4</day>;<volume>44</volume>(<issue>D1</issue>):<fpage>D457</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1070</pub-id>
<?supplied-pmid 26476454?><pub-id pub-id-type="pmid">26476454</pub-id></mixed-citation></ref><ref id="pone.0221446.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Fu</surname><given-names>L</given-names></name>, <name><surname>Niu</surname><given-names>B</given-names></name>, <name><surname>Zhu</surname><given-names>Z</given-names></name>, <name><surname>Wu</surname><given-names>S</given-names></name>, <name><surname>Li</surname><given-names>W</given-names></name>. <article-title>CD-HIT: accelerated for clustering the next-generation sequencing data</article-title>. <source>Bioinformatics</source>. <year>2012</year>
<month>12</month>
<day>1</day>;<volume>28</volume>(<issue>23</issue>):<fpage>3150</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bts565</pub-id>
<?supplied-pmid 23060610?><pub-id pub-id-type="pmid">23060610</pub-id></mixed-citation></ref><ref id="pone.0221446.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Ye</surname><given-names>Y-N</given-names></name>, <name><surname>Hua</surname><given-names>Z-G</given-names></name>, <name><surname>Huang</surname><given-names>J</given-names></name>, <name><surname>Rao</surname><given-names>N</given-names></name>, <name><surname>Guo</surname><given-names>F-B</given-names></name>. <article-title>CEG: a database of essential gene clusters</article-title>. <source>BMC Genomics</source>. <year>2013</year>
<month>11</month>
<day>9</day>;<volume>14</volume>:<fpage>769</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2164-14-769</pub-id>
<?supplied-pmid 24209780?><pub-id pub-id-type="pmid">24209780</pub-id></mixed-citation></ref><ref id="pone.0221446.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Hema K</surname></name>, <name><surname>VP</surname><given-names>I</given-names></name>, <name><surname>Pradhan</surname><given-names>D</given-names></name>, <name><surname>Munikumar</surname><given-names>M</given-names></name>, <name><surname>eep</surname><given-names>S S</given-names></name>, <etal>et al</etal>
<article-title>Identification of Putative Drug Targets and Vaccine Candidates for Pathogens Causing Atherosclerosis</article-title>. <source>Biochem Anal Biochem</source> [Internet]. <year>2015</year>
<month>4</month>
<day>17</day> [cited 2018 Aug 12];4(2). Available from: <ext-link ext-link-type="uri" xlink:href="https://www.omicsonline.org/open-access/identification-of-putative-drug-targets-and-vaccine-candidates-for-pathogens-causing-atherosclerosis-2161-1009-1000175.php?aid=53170">https://www.omicsonline.org/open-access/identification-of-putative-drug-targets-and-vaccine-candidates-for-pathogens-causing-atherosclerosis-2161-1009-1000175.php?aid=53170</ext-link></mixed-citation></ref><ref id="pone.0221446.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Moriya</surname><given-names>Y</given-names></name>, <name><surname>Itoh</surname><given-names>M</given-names></name>, <name><surname>Okuda</surname><given-names>S</given-names></name>, <name><surname>Yoshizawa</surname><given-names>AC</given-names></name>, <name><surname>Kanehisa</surname><given-names>M</given-names></name>. <article-title>KAAS: an automatic genome annotation and pathway reconstruction server</article-title>. <source>Nucleic Acids Res</source>. <year>2007</year>
<month>7</month>
<day>1</day>;<volume>35</volume>(<issue>suppl_2</issue>):<fpage>W182</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">17526522</pub-id></mixed-citation></ref><ref id="pone.0221446.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>C-S</given-names></name>, <name><surname>Chen</surname><given-names>Y-C</given-names></name>, <name><surname>Lu</surname><given-names>C-H</given-names></name>, <name><surname>Hwang</surname><given-names>J-K</given-names></name>. <article-title>Prediction of protein subcellular localization</article-title>. <source>Proteins Struct Funct Bioinforma</source>. <year>2006</year>;<volume>64</volume>(<issue>3</issue>):<fpage>643</fpage>&#x02013;<lpage>51</lpage>.</mixed-citation></ref><ref id="pone.0221446.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>NY</given-names></name>, <name><surname>Wagner</surname><given-names>JR</given-names></name>, <name><surname>Laird</surname><given-names>MR</given-names></name>, <name><surname>Melli</surname><given-names>G</given-names></name>, <name><surname>Rey</surname><given-names>S</given-names></name>, <name><surname>Lo</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes</article-title>. <source>Bioinformatics</source>. <year>2010</year>
<month>7</month>
<day>1</day>;<volume>26</volume>(<issue>13</issue>):<fpage>1608</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq249</pub-id>
<?supplied-pmid 20472543?><pub-id pub-id-type="pmid">20472543</pub-id></mixed-citation></ref><ref id="pone.0221446.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Karp</surname><given-names>PD</given-names></name>, <name><surname>Paley</surname><given-names>S</given-names></name>, <name><surname>Romero</surname><given-names>P</given-names></name>. <article-title>The Pathway Tools software</article-title>. <source>Bioinforma Oxf Engl</source>. <year>2002</year>;<volume>18</volume>
<issue>Suppl 1</issue>:<fpage>S225</fpage>&#x02013;<lpage>232</lpage>.</mixed-citation></ref><ref id="pone.0221446.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Pandey</surname><given-names>M</given-names></name>, <name><surname>Tiwari</surname><given-names>D</given-names></name>, <name><surname>Maurya</surname><given-names>S</given-names></name>, <name><surname>Singh</surname><given-names>D</given-names></name>, <name><surname>Srivastava</surname><given-names>P</given-names></name>. <article-title>Choke Point Analysis with Subtractive Proteomic Approach for Insilico Identification of Potential Drug Targets in Shigella Dysenteriae</article-title>. <source>Int J Comput Appl</source>. <year>2015</year>
<month>1</month>
<day>14</day>;<volume>109</volume>:<fpage>29</fpage>&#x02013;<lpage>34</lpage>.</mixed-citation></ref><ref id="pone.0221446.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Yeh</surname><given-names>I</given-names></name>, <name><surname>Hanekamp</surname><given-names>T</given-names></name>, <name><surname>Tsoka</surname><given-names>S</given-names></name>, <name><surname>Karp</surname><given-names>PD</given-names></name>, <name><surname>Altman</surname><given-names>RB</given-names></name>. <article-title>Computational Analysis of Plasmodium falciparum Metabolism: Organizing Genomic Information to Facilitate Drug Discovery</article-title>. <source>Genome Res</source>. <year>2004</year>
<month>5</month>
<day>1</day>;<volume>14</volume>(<issue>5</issue>):<fpage>917</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1101/gr.2050304</pub-id>
<?supplied-pmid 15078855?><pub-id pub-id-type="pmid">15078855</pub-id></mixed-citation></ref><ref id="pone.0221446.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Karp</surname><given-names>PD</given-names></name>, <name><surname>Billington</surname><given-names>R</given-names></name>, <name><surname>Caspi</surname><given-names>R</given-names></name>, <name><surname>Fulcher</surname><given-names>CA</given-names></name>, <name><surname>Latendresse</surname><given-names>M</given-names></name>, <name><surname>Kothari</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>The BioCyc collection of microbial genomes and metabolic pathways</article-title>. <source>Brief Bioinform</source> [Internet]. [cited 2019 May 5]; Available from: <ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/bib/advance-article/doi/10.1093/bib/bbx085/4084231">https://academic.oup.com/bib/advance-article/doi/10.1093/bib/bbx085/4084231</ext-link></mixed-citation></ref><ref id="pone.0221446.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Robert</surname><given-names>X</given-names></name>, <name><surname>Gouet</surname><given-names>P</given-names></name>. <article-title>Deciphering key features in protein structures with the new ENDscript server</article-title>. <source>Nucleic Acids Res</source>. <year>2014</year>
<month>7</month>;<volume>42</volume>(<issue>Web Server issue</issue>):<fpage>W320</fpage>&#x02013;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku316</pub-id>
<?supplied-pmid 24753421?><pub-id pub-id-type="pmid">24753421</pub-id></mixed-citation></ref><ref id="pone.0221446.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Webb</surname><given-names>B</given-names></name>, <name><surname>Sali</surname><given-names>A</given-names></name>. <article-title>Protein structure modeling with MODELLER</article-title>. <source>Methods Mol Biol Clifton NJ</source>. <year>2014</year>;<volume>1137</volume>:<fpage>1</fpage>&#x02013;<lpage>15</lpage>.</mixed-citation></ref><ref id="pone.0221446.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Krieger</surname><given-names>E</given-names></name>, <name><surname>Joo</surname><given-names>K</given-names></name>, <name><surname>Lee</surname><given-names>J</given-names></name>, <name><surname>Lee</surname><given-names>J</given-names></name>, <name><surname>Raman</surname><given-names>S</given-names></name>, <name><surname>Thompson</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8</article-title>. <source>Proteins</source>. <year>2009</year>;<volume>77</volume>
<issue>Suppl 9</issue>:<fpage>114</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">19768677</pub-id></mixed-citation></ref><ref id="pone.0221446.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Benkert</surname><given-names>P</given-names></name>, <name><surname>Biasini</surname><given-names>M</given-names></name>, <name><surname>Schwede</surname><given-names>T</given-names></name>. <article-title>Toward the estimation of the absolute quality of individual protein structure models</article-title>. <source>Bioinforma Oxf Engl</source>. <year>2011</year>
<month>2</month>
<day>1</day>;<volume>27</volume>(<issue>3</issue>):<fpage>343</fpage>&#x02013;<lpage>50</lpage>.</mixed-citation></ref><ref id="pone.0221446.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Wiederstein</surname><given-names>M</given-names></name>, <name><surname>Sippl</surname><given-names>MJ</given-names></name>. <article-title>ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins</article-title>. <source>Nucleic Acids Res</source>. <year>2007</year>
<month>7</month>;<volume>35</volume>(<issue>Web Server issue</issue>):<fpage>W407</fpage>&#x02013;<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkm290</pub-id>
<?supplied-pmid 17517781?><pub-id pub-id-type="pmid">17517781</pub-id></mixed-citation></ref><ref id="pone.0221446.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Tian</surname><given-names>W</given-names></name>, <name><surname>Chen</surname><given-names>C</given-names></name>, <name><surname>Lei</surname><given-names>X</given-names></name>, <name><surname>Zhao</surname><given-names>J</given-names></name>, <name><surname>Liang</surname><given-names>J</given-names></name>. <article-title>CASTp 3.0: computed atlas of surface topography of proteins</article-title>. <source>Nucleic Acids Res</source>. <year>2018</year>
<month>7</month>
<day>2</day>;<volume>46</volume>(<issue>W1</issue>):<fpage>W363</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky473</pub-id>
<?supplied-pmid 29860391?><pub-id pub-id-type="pmid">29860391</pub-id></mixed-citation></ref><ref id="pone.0221446.ref041"><label>41</label><mixed-citation publication-type="book"><name><surname>DeLano</surname><given-names>W.L.</given-names></name>
<source>The PyMOL Molecular Graphics System, San Carlos</source>. <year>2002</year>, <publisher-name>Schr&#x000f6;dinger, LLC</publisher-name></mixed-citation></ref><ref id="pone.0221446.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Cline</surname><given-names>MS</given-names></name>, <name><surname>Smoot</surname><given-names>M</given-names></name>, <name><surname>Cerami</surname><given-names>E</given-names></name>, <name><surname>Kuchinsky</surname><given-names>A</given-names></name>, <name><surname>Landys</surname><given-names>N</given-names></name>, <name><surname>Workman</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Integration of biological networks and gene expression data using Cytoscape</article-title>. <source>Nat Protoc</source>. <year>2007</year>;<volume>2</volume>(<issue>10</issue>):<fpage>2366</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2007.324</pub-id>
<?supplied-pmid 17947979?><pub-id pub-id-type="pmid">17947979</pub-id></mixed-citation></ref><ref id="pone.0221446.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Assenov</surname><given-names>Y</given-names></name>, <name><surname>Ram&#x000ed;rez</surname><given-names>F</given-names></name>, <name><surname>Schelhorn</surname><given-names>S-E</given-names></name>, <name><surname>Lengauer</surname><given-names>T</given-names></name>, <name><surname>Albrecht</surname><given-names>M</given-names></name>. <article-title>Computing topological parameters of biological networks</article-title>. <source>Bioinformatics</source>. <year>2008</year>
<month>1</month>
<day>15</day>;<volume>24</volume>(<issue>2</issue>):<fpage>282</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btm554</pub-id>
<?supplied-pmid 18006545?><pub-id pub-id-type="pmid">18006545</pub-id></mixed-citation></ref><ref id="pone.0221446.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Bader</surname><given-names>GD</given-names></name>, <name><surname>Hogue</surname><given-names>CW</given-names></name>. <article-title>An automated method for finding molecular complexes in large protein interaction networks</article-title>. <source>BMC Bioinformatics</source>. <year>2003</year>
<month>1</month>
<day>13</day>;<volume>4</volume>:<fpage>2</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2105-4-2</pub-id>
<?supplied-pmid 12525261?><pub-id pub-id-type="pmid">12525261</pub-id></mixed-citation></ref><ref id="pone.0221446.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Larkin</surname><given-names>MA</given-names></name>, <name><surname>Blackshields</surname><given-names>G</given-names></name>, <name><surname>Brown</surname><given-names>NP</given-names></name>, <name><surname>Chenna</surname><given-names>R</given-names></name>, <name><surname>McGettigan</surname><given-names>PA</given-names></name>, <name><surname>McWilliam</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Clustal W and Clustal X version 2.0</article-title>. <source>Bioinformatics</source>. <year>2007</year>
<month>11</month>
<day>1</day>;<volume>23</volume>(<issue>21</issue>):<fpage>2947</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btm404</pub-id>
<?supplied-pmid 17846036?><pub-id pub-id-type="pmid">17846036</pub-id></mixed-citation></ref><ref id="pone.0221446.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Chaemchuen</surname><given-names>S</given-names></name>, <name><surname>Rungpragayphan</surname><given-names>S</given-names></name>, <name><surname>Poovorawan</surname><given-names>Y</given-names></name>, <name><surname>Patarakul</surname><given-names>K</given-names></name>. <article-title>Identification of candidate host proteins that interact with LipL32, the major outer membrane protein of pathogenic Leptospira, by random phage display peptide library</article-title>. <source>Vet Microbiol</source>. <year>2011</year>
<month>11</month>
<day>21</day>;<volume>153</volume>(<issue>1</issue>):<fpage>178</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">21592685</pub-id></mixed-citation></ref><ref id="pone.0221446.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>La Scola</surname><given-names>B</given-names></name>, <name><surname>Bui</surname><given-names>LTM</given-names></name>, <name><surname>Baranton</surname><given-names>G</given-names></name>, <name><surname>Khamis</surname><given-names>A</given-names></name>, <name><surname>Raoult</surname><given-names>D</given-names></name>. <article-title>Partial rpoB gene sequencing for identification of Leptospira species</article-title>. <source>FEMS Microbiol Lett</source>. <year>2006</year>
<month>10</month>
<day>1</day>;<volume>263</volume>(<issue>2</issue>):<fpage>142</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.2006.00377.x</pub-id>
<?supplied-pmid 16978348?><pub-id pub-id-type="pmid">16978348</pub-id></mixed-citation></ref><ref id="pone.0221446.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Bourhy</surname><given-names>P</given-names></name>, <name><surname>Collet</surname><given-names>L</given-names></name>, <name><surname>Brisse</surname><given-names>S</given-names></name>, <name><surname>Picardeau</surname><given-names>M</given-names></name>. <article-title>Leptospira mayottensis sp. nov., a pathogenic species of the genus Leptospira isolated from humans</article-title>. <source>Int J Syst Evol Microbiol</source>. <year>2014</year>;<volume>64</volume>(<issue>12</issue>):<fpage>4061</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">25249563</pub-id></mixed-citation></ref><ref id="pone.0221446.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Nascimento</surname><given-names>ALTO</given-names></name>, <name><surname>Ko</surname><given-names>AI</given-names></name>, <name><surname>Martins</surname><given-names>E a. L</given-names></name>, <name><surname>Monteiro-Vitorello</surname><given-names>CB</given-names></name>, <name><surname>Ho</surname><given-names>PL</given-names></name>, <name><surname>Haake</surname><given-names>DA</given-names></name>, <etal>et al</etal>
<article-title>Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis</article-title>. <source>J Bacteriol</source>. <year>2004</year>
<month>4</month>;<volume>186</volume>(<issue>7</issue>):<fpage>2164</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1128/JB.186.7.2164-2172.2004</pub-id>
<?supplied-pmid 15028702?><pub-id pub-id-type="pmid">15028702</pub-id></mixed-citation></ref><ref id="pone.0221446.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Ren</surname><given-names>S-X</given-names></name>, <name><surname>Fu</surname><given-names>G</given-names></name>, <name><surname>Jiang</surname><given-names>X-G</given-names></name>, <name><surname>Zeng</surname><given-names>R</given-names></name>, <name><surname>Miao</surname><given-names>Y-G</given-names></name>, <name><surname>Xu</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing</article-title>. <source>Nature</source>. <year>2003</year>
<month>4</month>
<day>24</day>;<volume>422</volume>(<issue>6934</issue>):<fpage>888</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1038/nature01597</pub-id>
<?supplied-pmid 12712204?><pub-id pub-id-type="pmid">12712204</pub-id></mixed-citation></ref><ref id="pone.0221446.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Anishetty</surname><given-names>S</given-names></name>, <name><surname>Pulimi</surname><given-names>M</given-names></name>, <name><surname>Pennathur</surname><given-names>G</given-names></name>. <article-title>Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis</article-title>. <source>Comput Biol Chem</source>. <year>2005</year>
<month>10</month>;<volume>29</volume>(<issue>5</issue>):<fpage>368</fpage>&#x02013;<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1016/j.compbiolchem.2005.07.001</pub-id>
<?supplied-pmid 16213791?><pub-id pub-id-type="pmid">16213791</pub-id></mixed-citation></ref><ref id="pone.0221446.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Bian</surname><given-names>J</given-names></name>, <name><surname>Shen</surname><given-names>H</given-names></name>, <name><surname>Tu</surname><given-names>Y</given-names></name>, <name><surname>Yu</surname><given-names>A</given-names></name>, <name><surname>Li</surname><given-names>C</given-names></name>. <article-title>The Riboswitch Regulates a Thiamine Pyrophosphate ABC Transporter of the Oral Spirochete Treponema denticola</article-title>. <source>J Bacteriol</source>. <year>2011</year>
<month>8</month>
<day>1</day>;<volume>193</volume>(<issue>15</issue>):<fpage>3912</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00386-11</pub-id>
<?supplied-pmid 21622748?><pub-id pub-id-type="pmid">21622748</pub-id></mixed-citation></ref><ref id="pone.0221446.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Patra</surname><given-names>KP</given-names></name>, <name><surname>Choudhury</surname><given-names>B</given-names></name>, <name><surname>Matthias</surname><given-names>MM</given-names></name>, <name><surname>Baga</surname><given-names>S</given-names></name>, <name><surname>Bandyopadhya</surname><given-names>K</given-names></name>, <name><surname>Vinetz</surname><given-names>JM</given-names></name>. <article-title>Comparative analysis of lipopolysaccharides of pathogenic and intermediately pathogenic Leptospira species</article-title>. <source>BMC Microbiol</source>. <year>2015</year>
<month>10</month>
<day>30</day>;<volume>15</volume>(<issue>1</issue>):<fpage>244</fpage>.<pub-id pub-id-type="pmid">26518696</pub-id></mixed-citation></ref><ref id="pone.0221446.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Bulach</surname><given-names>DM</given-names></name>, <name><surname>Kalambaheti</surname><given-names>T</given-names></name>, <name><surname>de la Pe&#x000f1;a-Moctezuma</surname><given-names>A</given-names></name>, <name><surname>Adler</surname><given-names>B</given-names></name>. <article-title>Lipopolysaccharide biosynthesis in Leptospira</article-title>. <source>J Mol Microbiol Biotechnol</source>. <year>2000</year>
<month>10</month>;<volume>2</volume>(<issue>4</issue>):<fpage>375</fpage>&#x02013;<lpage>80</lpage>. <?supplied-pmid 11075908?><pub-id pub-id-type="pmid">11075908</pub-id></mixed-citation></ref><ref id="pone.0221446.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Taylor</surname><given-names>PL</given-names></name>, <name><surname>Blakely</surname><given-names>KM</given-names></name>, <name><surname>de Leon</surname><given-names>GP</given-names></name>, <name><surname>Walker</surname><given-names>JR</given-names></name>, <name><surname>McArthur</surname><given-names>F</given-names></name>, <name><surname>Evdokimova</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Structure and function of sedoheptulose-7-phosphate isomerase, a critical enzyme for lipopolysaccharide biosynthesis and a target for antibiotic adjuvants</article-title>. <source>J Biol Chem</source>. <year>2008</year>
<month>2</month>
<day>1</day>;<volume>283</volume>(<issue>5</issue>):<fpage>2835</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M706163200</pub-id>
<?supplied-pmid 18056714?><pub-id pub-id-type="pmid">18056714</pub-id></mixed-citation></ref><ref id="pone.0221446.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Raetz</surname><given-names>CRH</given-names></name>, <name><surname>Whitfield</surname><given-names>C</given-names></name>. <article-title>Lipopolysaccharide Endotoxins</article-title>. <source>Annu Rev Biochem</source>. <year>2002</year>
<month>6</month>
<day>1</day>;<volume>71</volume>(<issue>1</issue>):<fpage>635</fpage>&#x02013;<lpage>700</lpage>.<pub-id pub-id-type="pmid">12045108</pub-id></mixed-citation></ref><ref id="pone.0221446.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Charon</surname><given-names>NW</given-names></name>, <name><surname>Goldstein</surname><given-names>SF</given-names></name>. <article-title>Genetics of Motility and Chemotaxis of a Fascinating Group of Bacteria: The Spirochetes</article-title>. <source>Annu Rev Genet</source>. <year>2002</year>
<month>12</month>
<day>1</day>;<volume>36</volume>(<issue>1</issue>):<fpage>47</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">12429686</pub-id></mixed-citation></ref><ref id="pone.0221446.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Liao</surname><given-names>S</given-names></name>, <name><surname>Sun</surname><given-names>A</given-names></name>, <name><surname>Ojcius</surname><given-names>DM</given-names></name>, <name><surname>Wu</surname><given-names>S</given-names></name>, <name><surname>Zhao</surname><given-names>J</given-names></name>, <name><surname>Yan</surname><given-names>J</given-names></name>. <article-title>Inactivation of the fliY gene encoding a flagellar motor switch protein attenuates mobility and virulence of Leptospira interrogansstrain Lai</article-title>. <source>BMC Microbiol</source>. <year>2009</year>
<month>12</month>
<day>9</day>;<volume>9</volume>(<issue>1</issue>):<fpage>253</fpage>.<pub-id pub-id-type="pmid">20003186</pub-id></mixed-citation></ref><ref id="pone.0221446.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Ferla</surname><given-names>MP</given-names></name>, <name><surname>Patrick</surname><given-names>WM</given-names></name>. <article-title>Bacterial methionine biosynthesis</article-title>. <source>Microbiology</source>. <year>2014</year>;<volume>160</volume>(<issue>8</issue>):<fpage>1571</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">24939187</pub-id></mixed-citation></ref><ref id="pone.0221446.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Saint-Macary</surname><given-names>ME</given-names></name>, <name><surname>Barbisan</surname><given-names>C</given-names></name>, <name><surname>Gagey</surname><given-names>MJ</given-names></name>, <name><surname>Frelin</surname><given-names>O</given-names></name>, <name><surname>Beffa</surname><given-names>R</given-names></name>, <name><surname>Lebrun</surname><given-names>MH</given-names></name>, <etal>et al</etal>
<article-title>Methionine Biosynthesis is Essential for Infection in the Rice Blast Fungus Magnaporthe oryzae</article-title>. <source>PLOS ONE</source>. <year>2015</year>
<month>4</month>
<day>9</day>;<volume>10</volume>(<issue>4</issue>):<fpage>e0111108</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0111108</pub-id>
<?supplied-pmid 25856162?><pub-id pub-id-type="pmid">25856162</pub-id></mixed-citation></ref></ref-list></back></article>